content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
  
  <P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>As
  filed with the Securities and Exchange Commission on May 22, 2017</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Registration
  No. 333-________</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  <!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNITED
  STATES</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SECURITIES
  AND EXCHANGE COMMISSION</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Washington,
  D.C. 20549</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM
  S-8</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>REGISTRATION
  STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>HealthLynked
  Corp.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Exact
  name of registrant as specified in its charter)</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Nevada</B></FONT></TD>
      <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>47-1634127</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 49%; font-family: Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(State
  or other jurisdiction of</FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">incorporation
          or organization)</FONT></P></TD>
      <TD STYLE="width: 2%">&nbsp;</TD>
      <TD STYLE="width: 49%; font-family: Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(I.R.S.
  Employer</FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Identification
          No.)</FONT></P></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>1726
  Medical Blvd Suite 101</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>Naples,
  Florida 34110</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Address
  of principal executive offices) (Zip Code)</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2016
  Equity Incentive Plan</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Full
  title of the plan)</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Michael
  Dent, MD</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Chief
  Executive Officer</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>HealthLynked
  Corp.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>1726
  Medical Blvd Suite 101</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>Naples,
  Florida 34110</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Name
  and Address of agent for service)</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>(239)
  513-1992</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Telephone
  number, including area code, of agent for service)</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">With
  a copy to:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gregory
  Sichenzia, Esq.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Avital
  Perlman, Esq.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Sichenzia
  Ross Ference Kesner LLP</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">61
  Broadway, 32<SUP>nd</SUP> Floor</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">New
  York, NY 10006</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Phone
  (212) 930-9700</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fax
  (212) 930-9725</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
  by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
  company or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
  &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 34%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
      accelerated filer &#9744;</FONT></TD>
      <TD STYLE="width: 33%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
      filer&nbsp;&nbsp;&nbsp;&#9744;</FONT></TD>
      <TD STYLE="width: 33%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
      filer&nbsp;&nbsp; &#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
      Reporting Company&nbsp;&#9746;</FONT></TD>
      <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Emerging
      Growth Company &#9746;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
  an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
  complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
  &#9744;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CALCULATION
  OF REGISTRATION FEE</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Title of Securities to be Registered</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount to be<BR> Registered (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed<BR> Maximum Offering <BR> Price Per Share</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed <BR> Maximum <BR> Aggregate Offering <BR> Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount of<BR> Registration Fee</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="width: 52%">Common Stock, $0.0001 par value</TD><TD STYLE="width: 1%">&nbsp;</TD>
      <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,049,996</TD><TD STYLE="width: 1%; text-align: left">(2)</TD><TD STYLE="width: 1%">&nbsp;</TD>
      <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.12</TD><TD STYLE="width: 1%; text-align: left">(3)</TD><TD STYLE="width: 1%">&nbsp;</TD>
      <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">245,999.52</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
      <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">28.51</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD>Common Stock, $0.0001 par value</TD><TD>&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,467,500</TD><TD STYLE="text-align: left">(4)</TD><TD>&nbsp;</TD>
      <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.80</TD><TD STYLE="text-align: left">(5)</TD><TD>&nbsp;</TD>
      <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,174,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
      <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">136.07</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="text-align: left; padding-bottom: 1.5pt">Common Stock, $0.0001 par value to be issued under the Plan</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,986,184</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">(6)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
      <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.80</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">(5)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,588,947.20</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,111.36</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font-weight: bold; padding-bottom: 4pt">TOTAL</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">15,503,680</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
      <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,470,799.36</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,275.94</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 4%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
      <TD STYLE="width: 96%; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
      Registration Statement also registers an indeterminable number of additional securities to be offered or issued upon adjustments
      or changes made to registered securities by reason of any stock splits, stock dividends or similar transactions as permitted
      by Rule 416(a) and Rule 416(b) under the Securities Act of 1933, as amended, or the Securities Act.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
      shares of common stock issuable pursuant to stock option awards outstanding under the 2016 Equity Incentive Plan (the &ldquo;Plan&rdquo;).</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
      solely for the purpose of calculating the registration fee pursuant to Rule 457(h) under the Securities Act, and based upon
      the weighted average price at which such options may be exercised.&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
      common stock awards issued under the Plan.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Estimated
          solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) under the Securities Act. The
          fee is calculated on the basis of the average of the high and low sale prices for the registrant&rsquo;s common stock
          as reported on the OTCQB on May 19, 2017.</FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
      shares of common stock reserved for future issuance pursuant to the Plan.</FONT></TD></TR>
  </TABLE>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EXPLANATORY
  NOTE</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
  registration statement registers 2,049,996 shares of common stock, par value $0.0001 per share, of HealthLynked Corp. (&ldquo;we&rdquo;,
  &ldquo;us&rdquo;, &ldquo;our&rdquo;, the &ldquo;Company&rdquo; or &ldquo;Registrant&rdquo;) underlying options previously granted
  under the HealthLynked Corp. 2016 Equity Incentive Plan (the &ldquo;Plan), 1,467,500 shares of restricted stock previously granted
  under the Plan, and 11,986,184 shares of common stock reserved for issuance under the Plan.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
  Registration Statement also includes a prospectus (which we refer to as the reoffer prospectus) prepared in accordance with General
  Instruction C of Form S-8 and in accordance with the requirements of Part I of Form S-3. The reoffer prospectus may be used for
  reofferings and resales of certain of the shares of our common stock listed above that may be deemed to be &ldquo;control securities&rdquo;
  and/or &ldquo;restricted securities&rdquo; under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and
  the rules and regulations promulgated thereunder. These are shares that were or may be acquired by our officers, directors and
  affiliates, or that were acquired by our employees or consultants, under an employee benefit plan. Such officers, directors, affiliates,
  employees and consultants are the selling stockholders identified in the reoffer prospectus.&nbsp;The amount of shares to be offered
  or resold by means of this reoffer prospectus by each selling stockholder, and any other person with whom he or she is acting
  in concert for the purpose of selling our securities, may not exceed, during any three-month period, the amount specified in Rule
  144(e) of the Securities Act.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PART
  I</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>INFORMATION
  REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 8%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
      1.</B></FONT></TD>
      <TD STYLE="width: 92%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Plan
      Information.</B></FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Company will provide each recipient of a grant under the Plan (the &ldquo;Recipients&rdquo;) with documents that contain information
  related to the Plan, and other information including, but not limited to, the disclosure required by Item 1 of Form S-8, which
  information is not required to be and are not being filed as a part of this Registration Statement on Form S-8 (the &ldquo;Registration
  Statement&rdquo;) or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. The foregoing information
  and the documents incorporated by reference in response to Item 3 of Part II of this Registration Statement, taken together, constitute
  a prospectus that meets the requirements of Section 10(a) of the Securities Act. A Section 10(a) prospectus will be given to each
  Recipient who receives common stock covered by this Registration Statement, in accordance with Rule 428(b)(1) under the Securities
  Act.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 8%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
      2.</B></FONT></TD>
      <TD STYLE="width: 92%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrant
      Information and Employee Plan Annual Information.</B></FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  will provide to each Recipient a written statement advising of the availability of documents incorporated by reference in Item
  3 of Part II of this Registration Statement (which documents are incorporated by reference in this Section 10(a) prospectus) and
  of documents required to be delivered pursuant to Rule 428(b) under the Securities Act without charge and upon written or oral
  request by contacting:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">George
  O&rsquo;Leary</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief
  Financial Officer</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">HealthLynked
  Corp.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">1726
  Medical Blvd Suite 101</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Naples,
  Florida 34110</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  
  <!-- Field: Page; Sequence: 4 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>REOFFER
  PROSPECTUS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3,517,496
  Shares</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Common
  Stock</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issued
  or issuable under certain awards </B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>granted
  under the Plan</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
  reoffer prospectus relates to the public resale, from time to time, of an aggregate of 3,517,496 shares (the &ldquo;Shares&rdquo;)
  of our common stock, $0.0001 par value per share by certain securityholders identified herein in the section entitled &ldquo;Selling
  Securityholders&rdquo;. Such shares have been or may be acquired in connection with awards granted under the HealthLynked
  Corp. 2016 Equity Incentive Plan (the &ldquo;Plan&rdquo;). The amount of shares to be reoffered or resold by means of this prospectus
  by each Selling Securityholder, and any other person with whom such Selling Securityholder is acting in concert for the purpose
  of selling our securities, may not exceed, during any three-month period, the amount specified in Rule&nbsp;144(e)&nbsp;of the
  Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). You should read this prospectus carefully before you invest
  in our common stock.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Such
  resales shall take place on the OTCQB, or such other stock market or exchange on which our common stock may be listed or quoted,
  in negotiated transactions or otherwise, at market prices prevailing at the time of the sale or at prices otherwise negotiated
  (see &ldquo;Plan of Distribution&rdquo; starting on page 22 of this prospectus). We will receive no part of the proceeds from
  sales made under this reoffer prospectus. The Selling Securityholders will bear all sales commissions and similar expenses. Any
  other expenses incurred by us in connection with the registration and offering and not borne by the Selling Securityholders will
  be borne by us.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
  reoffer prospectus has been prepared for the purposes of registering the common shares under the Securities Act to allow for future
  sales by Selling Securityholders on a continuous or delayed basis to the public without restriction. We have not entered into
  any underwriting arrangements in connection with the sale of the shares covered by this reoffer prospectus. The Selling Securityholders
  identified in this reoffer prospectus, or their pledgees, donees, transferees or other successors-in-interest, may offer the shares
  covered by this reoffer prospectus from time to time through public or private transactions at prevailing market prices, at prices
  related to prevailing market prices or at privately negotiated prices.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investing
  in our common stock involves risks. See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;4 of this reoffer prospectus. These are
  speculative securities.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  common stock is quoted on the OTCQB under the symbol &ldquo;HLYK&rdquo; and the last reported sale price of our common stock on
  May 19, 2017 was $0.80 per share.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NEITHER
  THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR
  DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  date of this prospectus is May 22, 2017</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  
  <!-- Field: Page; Sequence: 5 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>HEALTHLYNKED
  CORP.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="toc"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TABLE
  OF CONTENTS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; width: 91%; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; width: 8%; text-align: center; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><B>Page</B></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary
      Statement Regarding Forward-Looking Statements</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">1</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; background-color: White">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus
      Summary</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">2</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
      Factors</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">4</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; background-color: White">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
      of Proceeds</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">18</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
      Securityholders</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">19</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; background-color: White">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
      of Distribution</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">22</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a7"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
      Matters</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">23</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; background-color: White">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a8"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">23</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a9"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation
      of Certain Documents by Reference</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">24</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; background-color: White">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a10"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
      of Commission Position on Indemnification For Securities Act Liabilities</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">24</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><A HREF="#a11"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
      You can Find Additional Information</FONT></A></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif">24</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  
  <!-- Field: Page; Sequence: 6 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Except
  where the context otherwise requires, the terms, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; or &ldquo;the Company,&rdquo;
  refer to the business of HealthLynked Corp., a Nevada corporation, and its wholly-owned subsidiary Naples Women&rsquo;s Center
  LLC (&ldquo;NWC&rdquo;). </I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a1"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CAUTIONARY
  STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
  prospectus contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs
  or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development
  plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking
  statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such
  statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks
  described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date
  hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking
  statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based
  on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal
  surveys, independent industry publications and other publicly available information.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 99%">
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a2"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PROSPECTUS
  SUMMARY</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>The
  Securities and Exchange Commission (the &ldquo;Commission&rdquo;) allows us to &rsquo;&lsquo;incorporate by reference&rsquo;&rsquo;
  certain information that we file with the Commission, which means that we can disclose important information to you by referring
  you to those documents. The information incorporated by reference is considered to be part of this prospectus, and information
  that we file later with the Commission will update automatically, supplement and/or supersede the information disclosed in this
  prospectus. Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus shall
  be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus
  or in any other document that also is or is deemed to be incorporated by reference in this prospectus modifies or supersedes such
  statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute
  a part of this prospectus. You should read the following summary together with the more detailed information regarding our company,
  our common stock and our financial statements and notes to those statements appearing elsewhere in this prospectus or incorporated
  herein by reference.</I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Overview</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">HealthLynked
  is a Nevada corporation formed in August 2014. We are the provider of a cloud-based service, the HealthLynked Network, which is
  a fully integrated web site that that enables patients and their providers to record, archive and access patients&rsquo; medical
  information, book real time and future appointments via the internet and physician encounters via telemedicine. We currently anticipate
  launching the network in the first half of 2017 under the domain name &ldquo;www.HealthLynked.com&rdquo;.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">At
  <U>www.HealthLynked.com</U>, patients will be able to complete a detailed personal medical history, including current medications,
  past surgical history, allergies and family medical history. Patients and their treating physicians will also be able to update
  the information as needed to provide an up to date and complete medical record. The HealthLynked Network will be accessible 24
  hours a day, seven days a week on web browsers and on a mobile phone application. We believe that the HealthLynked Network will
  provide numerous benefits for patients, medical providers, hospitals, emergency rooms and schools. Further, we believe that wait
  times in physicians&rsquo; offices will be shortened by avoiding the need for repetitive paperwork thereby reducing intake times and
  allowing physicians to see more patients and have more accurate patient information.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  </DIV>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 8; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 99%">
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Patient
  data will be stored in conformity with the <I>Health Insurance Portability and Accountability Act</I> of 1996, or &ldquo;HIPAA&rdquo;.
  The network will utilize Amazon AWS infrastructure which will use Amazon &ldquo;HIPPA&rdquo; Complaint Servers along with Amazon
  RDS with LAMP, HTML5 and several JavaScript framework, including Angular and React. Recommendations for end users are 512 kbps+
  internet connection speed and a web browser such as Google Chrome, Internet Explorer, Mozilla Firefox, Safari or handheld devices
  such as iOS devices, android phones or tablets. Our developers may utilize third party controls for functionality or user interface
  where the use of those controls adds value to the system beyond custom creation of new tools. We intend to adjust forward compatibility
  for major browser version updates, new browsers, operating system updates or new operating system as needed. The HealthLynked
  Network will be electronic medical record (&ldquo;EMR&rdquo;) agnostic and will be compatible with all electronic medical records
  systems, allowing for minimal barriers to participation and broader penetration of the market.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
  September 2014, we acquired the Naples Women&rsquo;s Center (&ldquo;NWC&rdquo;) an OB/GYN practice in Naples, Florida that was formed
  in 1996 by Dr. Michael Dent, our Chief Executive Officer and Chairman. At the time of the acquisition, NWC was a related party.
  Through NWC, we offer various services including Obstetrical services for high and low risk patients, in office ultrasonography,
  and prenatal testing. We also provide gynecological services that include general physical exams, surgical procedures such as
  hysterectomy, bladder incontinence procedures, pelvic reconstruction, sterilization, endometrial ablation, advanced robotic surgery,
  contraceptive management and infertility testing and treatment. We believe that this acquisition provides a foundation for ongoing
  development of the HealthLynked Network by allowing us to register NWC&rsquo;s approximately 6,000 active patients and to utilize
  the expertise of our employed physicians to help in the design and strategy for deployment of the HealthLynked Network. It is
  anticipated that in the future, we may acquire other medical practices as we see fit to further develop, test and deploy the HealthLynked
  Network into new strategic regional areas throughout the country. &nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Corporate
  Information</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  were incorporated on August 6, 2014 under the laws of the State of Nevada. On October 11, 2011, we changed our name to HealthLynked
  Corp. In August 2014, we acquired the NWC, an OB/GYN practice in Naples, Florida that was established in 1996. Our principal executive
  offices are located at <FONT STYLE="background-color: white">1726 Medical Blvd Suite 101, Naples, Florida 34110</FONT> and our
  telephone number is (<FONT STYLE="background-color: white">239) 513-1992</FONT>. &nbsp; &nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The
  Offering</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; width: 25%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
      Common Stock:</B></FONT></TD>
      <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; width: 74%; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,703,640
      shares of our common stock are outstanding as of May 19, 2017.</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
      Stock Offered:</B></FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
      to 3,517,496 shares of common stock for sale by the Selling Securityholders (which include our executive officers and directors)
      for their own account pursuant to the Plan.</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling
      Securityholders:</B></FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Selling Securityholders are set forth in the section entitled &ldquo;Selling Securityholders&rdquo; of this reoffer prospectus
      on page 19.</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
      of proceeds:</B></FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
      will not receive any proceeds from the sale of our common stock by the Selling Securityholders. We would, however, receive
      proceeds upon the exercise of the stock options by those who receive options under the Plans and exercise such options for
      cash. Any cash proceeds will be used by us for general corporate purposes.</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
      Factors:</B></FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      securities offered hereby involve a high degree of risk. See &ldquo;Risk Factors.&rdquo;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTCQB
      trading symbol:</B></FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">HLYK</FONT></P></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  </DIV>
  
  
  <!-- Field: Page; Sequence: 9; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a3"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RISK
  FACTORS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>You
  should carefully consider the risks described below before making an investment decision. The risks described below are not the
  only ones we face. Additional risks we are not presently aware of or that we currently believe are immaterial may also impair
  our business operations. Our business could be harmed by any of these risks. The trading price of our common stock could decline
  due to any of these risks, and you may lose all or part of your investment. In assessing these risks, you should also refer to
  the other information contained or incorporated by reference into this prospectus, including our financial statements and related
  notes.</I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I>FINANCIAL
  AND GENERAL BUSINESS RISKS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B>&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
  subsidiary the Naples Women&rsquo;s Center, currently our only source of income, has achieved profitability and incurred losses
  in the past and may not be able to achieve profitability in the future.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
  though our subsidiary the Naples Women&rsquo;s Center (&ldquo;NWC&rdquo;) was established in 1996, it is subject to many of the
  risks inherent in the practice of medicine. We cannot give any assurance that NWC&rsquo;s operations will continue as currently
  intended and no assurance can be given that we can continue to receive reimbursement from third party payers. Further, changes
  in Healthcare regulations in the coming years may negatively impact our operations. NWC realized segment income from operations
  for the year ended December 31, 2015, but incurred segment losses in the years ended December 31, 2014 and 2016 as well as in
  the three months ended March 31, 2017 and 2016. We expect to hire approximately five additional new physicians over the next two
  to five years, which will result in increased costs and expenses, which may result in future operating losses.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may never be able to implement our proposed online personal medical information and archiving system and as such, an investment
  in us at this stage of our business is extremely risky.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  HealthLynked Network is in the developmental stages and we currently anticipate launching the network sometime during the first
  six months of 2017. However, we cannot guarantee how long it will take us to develop our technology. In addition, we cannot predict
  whether physicians and patients will adopt our technology, or even if they do, the timing of such adoption. Further, it is possible
  that other competitors will greater resources could enter the market and make it more difficult for us to attract or keep customers.
  Consequently, at this phase of our development, our future is speculative and depends on the proper execution of our business
  model.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>No
  assurance can be given that we will be able to timely repay the amounts due on our convertible notes.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
  July 2016, we issued a 6% fixed convertible secured promissory note due July 11, 2017 in the principal amount of $550,000 (the
  &ldquo;Secured Note&rdquo;). At any time and from time to time, the holder of the note may convert, in whole or in part, the outstanding
  and unpaid principal amount under the Secured Note into shares of the Company&rsquo;s common stock at a conversion price of $0.08
  per share. In addition, we also issued a 10% fixed convertible commitment fee promissory note due July 11, 2017 in the principal
  amount of $50,000 (the &ldquo;Fee Note&rdquo; and collectively with the Secured Note, the &ldquo;Convertible Notes&rdquo;). At
  the present time, no assurance can be given that we will earn sufficient revenues or secure the necessary financing, if needed,
  to timely pay the amounts owed under the Convertible Notes. The Secured Note is secured by substantially all of our assets, including,
  but not limited to, receivables of NWC, machinery, equipment, contracts rights, and letters of credits. If we fail to timely repay
  the amounts owed under the Secured Note, a default may allow the lender under the relevant instruments to accelerate the related
  debt and to exercise their remedies under these agreements, which will typically include the right to declare the principal amount
  of that debt, together with accrued and unpaid interest and other related amounts, immediately due and payable, to exercise any
  remedies the lender may have to foreclose on assets that are subject to liens securing that debt. As of March 31, 2017, $574,140
  in principal and interest was outstanding under the Secured Note and $52,425 in principal and interest was outstanding under the
  Fee Note. We expect to repay the Convertible Notes from outside funding sources, including but not limited to amounts available
  upon the exercise of the Put Right granted to us under an investment agreement entered into in July 2016 (the &ldquo;Investment
  Agreement&rdquo;) with Iconic Holdings LLC (&ldquo;Iconic&rdquo;), sales of our equity, loans from related parties and others,
  or to satisfy the Convertible Notes through the issuance of shares upon conversion pursuant to the terms of the Convertible Notes.
  No assurances can be given that we will be able to access sufficient outside capital in a timely fashion in order to repay the
  Convertible Notes before they mature. In order to access cash available under the Investment Agreement or satisfy the Convertible
  Notes through the issuance of shares upon conversion, our common stock must be listed on a recognized stock exchange or market
  and the shares underlying the arrangement must be subject to an effective registration statement. If we are unable to meet these
  requirements, we will not have access to funds under this arrangement.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 10; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  have substantial future capital needs and our ability to continue as a going concern depends upon our ability to raise additional
  capital and achieve profitable operations.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  currently anticipate that our available cash resources will be sufficient to meet our presently anticipated working capital requirements
  through the second quarter of 2017. However, we anticipate that we will need an additional $250,000 in the third and fourth quarters
  of 2017 to properly execute our business plan. We may also need to raise additional funds in order to support more rapid expansion,
  develop new or enhanced services and products, hire employees, respond to competitive pressures, acquire technologies or respond
  to unanticipated requirements. Management&rsquo;s plans include attempting to improve our profitability and our ability to generate
  sufficient cash flow from operations to meet our operating needs on a timely basis, obtaining additional working capital funds
  through equity and debt financing arrangements, and restructuring on-going operations to eliminate inefficiencies to increase
  our cash balances. However, there can be no assurance that these plans and arrangements will be sufficient to fund our ongoing
  capital expenditures, working capital, and other requirements. Management intends to make every effort to identify and develop
  sources of funds. The outcome of these matters cannot be predicted at this time. There can be no assurance that any additional
  financings will be available to the Company on satisfactory terms and conditions, if at all. If adequate funds are not available
  on acceptable terms, we may be unable to develop or enhance our services and products, take advantage of future opportunities
  or respond to competitive pressures or unanticipated requirements, which could have a material adverse effect on our business,
  financial condition and operating results. Further, we may seek to raise additional funds through the issuance of equity securities,
  in which case, the percentage ownership of our shareholders will be reduced and holders may experience additional dilution in
  net book value per share.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
  future success depends on our ability to execute our business plan by fully developing our online medical records platform and
  recruiting physicians and patients to adopt and use the system. However, there is no guarantee that we will be able to successfully
  implement our business plan.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  operations to date have been limited to the medical services provided by the NWC. The online medical records platform we seek
  to provide through the HealthLynked Network is in the early stages of development and as such, we have not yet demonstrated our
  ability to successfully develop or market this platform. As of the date of this prospectus, we have not entered into any agreements
  with third party doctors or patients to use our system for their medical records and there is no assurance that we will be able
  to enter into such agreements in the future.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may not be able to effectively control and manage our growth.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  strategy envisions a period of potentially rapid growth in our physician network over the next five years based on aggressively
  increasing our marketing efforts. We intend to rely on the efforts of our newly engaged Chief Commercial Officer to attempt to
  enroll over 2,000 new physicians by December 2017 with that level of growth doubling every year over the next five years. We currently
  maintain a small in house programming, IT, administrative and sales personnel. The capacity to service the online medical records
  platform and our expected growth may impose a significant burden on our future planned administrative and operational resources.
  The growth of our business may require significant investments of capital and increased demands on our management, workforce and
  facilities. We will be required to substantially expand our administrative and operational resources and attract, train, manage
  and retain qualified employees, management and other personnel. Failure to do so, or to satisfy such increased demands would interrupt
  or have a material adverse effect on our business and results of operations.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 11; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
  departure or loss of Dr. Michael Dent could disrupt our business.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  depend heavily on the continued efforts of Dr. Michael Dent, Chief Executive Officer and Chairman of the Board. Dr. Dent is essential
  to our strategic vision and day-to-day operations and would be difficult to replace. While we have entered into a four-year written
  employment contract with Dr. Dent effective July 1, 2016, we cannot be certain that Dr. Dent will continue with us for any particular
  period of time. The departure or loss of Dr. Dent, or the inability to hire and retain a qualified replacement, could negatively
  impact our ability to manage our business.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
  departure or loss of Robert Horel, our Chief Commercial Officer, could disrupt our business.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  depend heavily on the continued efforts of Robert Horel, our Chief Commercial Officer. Mr. Horel&rsquo;s expertise and contacts
  are essential to our sales strategy and would be difficult to replace. While we have entered into a written employment contract
  with Mr. Horel effective November 28, 2016, we cannot be certain that Mr. Horel will continue with us for any particular period
  of time. The departure or loss of Mr. Horel, or the inability to hire and retain a qualified replacement, could negatively impact
  our ability to manage our business.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>George
  O&rsquo;Leary <FONT STYLE="background-color: white">may devote only a portion of his business time to us, which could materially
  and adversely affect us and our business</FONT>.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
  O&rsquo;Leary, our Chief Financial Officer, has entered into a two-year consultancy agreement with us effective July 1, 2016.
  However, under the terms of such agreement, he is not required to work exclusively for us and does not devote all of his time
  to our operations. Presently, Mr. O&rsquo;Leary allocates only a portion of his time to the operation of our business. As Mr.
  O&rsquo;Leary is currently providing consulting services elsewhere in addition to serving as our Chief Financial Officer, he is
  able to commit to us only up to twenty-five hours a week but is not obligated to devote any particular amount of time to our business
  or affairs.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
  healthcare industry is highly regulated, and government authorities may determine that we have failed to comply with applicable
  laws, rules or regulations.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  healthcare industry, healthcare information technology, the online medical records platform services that we provide and the physicians&rsquo;
  medical practices we engage in through NWC are subject to extensive and complex federal, state and local laws, rules and regulations,
  compliance with which imposes substantial costs on us. Of particular importance are the provisions summarized as follows:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
      laws (including the federal False Claims Act) that prohibit entities and individuals from knowingly or recklessly making claims
      to Medicaid, Medicare and other government-funded programs that contain false or fraudulent information or from improperly
      retaining known overpayments;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
      provision of the Social Security Act, commonly referred to as the &ldquo;anti-kickback&rdquo; statute, that prohibits the
      knowing and willful offer, payment, solicitation or receipt of any bribe, kickback, rebate or other remuneration, in cash
      or in kind, in return for the referral or recommendation of patients for items and services covered, in whole or in part,
      by federal healthcare programs, such as Medicaid and Medicare;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
      provision of the Social Security Act, commonly referred to as the Stark Law, that, subject to limited exceptions, applies
      when physicians refer Medicare patients to an entity for the provision of certain &ldquo;designated health services&rdquo;
      if the physician or a member of such physician&rsquo;s immediate family has a direct or indirect financial relationship (including
      a compensation arrangement) with the entity;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">similar
      state law provisions pertaining to anti-kickback, fee splitting, self-referral and false claims issues, which typically are
      not limited to relationships involving government-funded programs;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provisions
      of the <FONT STYLE="background-color: white">federal Health Insurance Portability and Accountability Act of 1996, as amended
      (&ldquo;HIPAA&rdquo;)</FONT> that prohibit knowingly and willfully executing a scheme or artifice to defraud a healthcare
      benefit program or falsifying, concealing or covering up a material fact or making any material false, fictitious or fraudulent
      statement in connection with the delivery of or payment for healthcare benefits, items or services;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">state
      laws that prohibit general business corporations from practicing medicine, controlling physicians&rsquo; medical decisions
      or engaging in certain practices, such as splitting fees with physicians;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 12; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
      and state healthcare programs may deny our application to become a participating provider that could in turn cause us to not
      be able to treat those patients or prohibit us from billing for the treatment services provided to such patients;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
      and state laws that prohibit providers from billing and receiving payment from Medicaid or Medicare for services unless the
      services are medically necessary, adequately and accurately documented and billed using codes that accurately reflect the
      type and level of services rendered;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
      and state laws pertaining to the provision of services by non-physician practitioners, such as advanced nurse practitioners,
      physician assistants and other clinical professionals, physician supervision of such services and reimbursement requirements
      that may be dependent on the manner in which the services are provided and documented; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
      laws that impose civil administrative sanctions for, among other violations, inappropriate billing of services to federally
      funded healthcare programs, inappropriately reducing hospital care lengths of stay for such patients, or employing individuals
      who are excluded from participation in federally funded healthcare programs.</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
  addition, we believe that our business, including the business conducted through NWC, will continue to be subject to increasing
  regulation, the scope and effect of which we cannot predict.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  may in the future become the subject of regulatory or other investigations or proceedings, and our interpretations of applicable
  laws, rules and regulations may be challenged. For example, regulatory authorities or other parties may assert that our arrangements
  with the physicians using the HealthLynked Network constitute fee splitting and seek to invalidate these arrangements, which could
  have a material adverse effect on our business, financial condition, results of operations, cash flows and the trading price of
  our common stock. Regulatory authorities or other parties also could assert that our relationships violate the anti-kickback,
  fee splitting or self-referral laws and regulations. Such investigations, proceedings and challenges could result in substantial
  defense costs to us and a diversion of management&rsquo;s time and attention. In addition, violations of these laws are punishable
  by monetary fines, civil and criminal penalties, exclusion from participation in government-sponsored healthcare programs, and
  forfeiture of amounts collected in violation of such laws and regulations, any of which could have a material adverse effect on
  our overall business, financial condition, results of operations, cash flows and the trading price of our common stock.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Federal
  and state laws that protect the privacy and security of protected health information may increase our costs and limit our ability
  to collect and use that information and subject us to penalties if we are unable to fully comply with such laws.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Numerous
  federal and state laws and regulations govern the collection, dissemination, use, security and confidentiality of individually
  identifiable health information. These laws include:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
      of HIPAA that limit how healthcare providers may use and disclose individually identifiable health information, provide certain
      rights to individuals with respect to that information and impose certain security requirements;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Health Information Technology for Economic and Clinical Health Act (&ldquo;HITECH&rdquo;), which strengthens and expands the
      HIPAA Privacy Standards and Security Standards and imposes data breach notification obligations;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
      federal and state laws restricting the use and protecting the privacy and security of protected health information, many of
      which are not preempted by HIPAA;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
      and state consumer protection laws; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
      and state laws regulating the conduct of research with human subjects.</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 13; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Through
  the HealthLynked Network, we collect and maintain protected health information in paper and electronic format. New protected health
  information standards, whether implemented pursuant to HIPAA, HITECH, congressional action or otherwise, could have a significant
  effect on the manner in which we handle healthcare-related data and communicate with third parties, and compliance with these
  standards could impose significant costs on us, or limit our ability to offer certain services, thereby negatively impacting the
  business opportunities available to us.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
  addition, if we do not comply with existing or new laws and regulations related to protected health information, we could be subject
  to remedies that include monetary fines, civil or administrative penalties, civil damage awards or criminal sanctions.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RISKS
  RELATED TO THE HEALTHLYNKED NETWORK</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
  market for Internet-based personal medical information and record archiving systems may not develop substantially further or develop
  more slowly than we expect, harming the growth of our business.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">It
  is uncertain whether personal medical information and record archiving systems will achieve and sustain the high levels of demand
  and market acceptance we anticipate. Further, even though we expect NWC patients and physicians to use the HealthLynked Network,
  our success will depend, to a substantial extent, on the willingness of unaffiliated patients, physicians and hospitals to use
  our services. Some patients, physicians and hospitals may be reluctant or unwilling to use our services, because they may have
  concerns regarding the risks associated with the security and reliability, among other things, of the technology model associated
  with these services. If our target users do not believe our systems are secure and reliable, then the market for these services
  may not expand as much or develop as quickly as we expect, either of which would significantly adversely affect our business,
  financial condition, or operating results.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
  we do not continue to innovate and provide services that are useful to our target users, we may not remain competitive, and our
  revenues and operating results could suffer.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  success depends on our ability to keep pace with technological developments, satisfy increasingly sophisticated client requirements,
  and obtain market acceptance. Our competitors are constantly developing products and services that may become more efficient or
  appealing to our clients and users. As a result, we will be required to invest significant resources in research and development
  in order to enhance our existing services and introduce new high-quality services that clients and users will want, while offering
  these services at competitive prices.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
  we are unable to predict user preferences or industry changes, or if we are unable to modify our services on a timely or cost-effective
  basis, we may lose clients and target users. Our operating results would also suffer if our innovations are not responsive to
  the needs of our clients and users, are not appropriately timed with market opportunity, or are not effectively brought to market.
  As technology continues to develop, our competitors may be able to offer results that are, or that are perceived to be, substantially
  similar to or better than those generated by our services. This may force us to compete on additional service attributes and to
  expend significant resources in order to remain competitive.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Failure
  to manage our rapid growth effectively could increase our expenses, decrease our revenue, and prevent us from implementing our
  business strategy.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
  manage our anticipated future growth effectively, we will need to enhance our information technology infrastructure and financial
  and accounting systems and controls, as well as manage expanded operations in geographically distributed locations. We also must
  engage and retain a significant number of qualified professional services personnel, software engineers, technical personnel,
  and management personnel. Failure to manage our rapid growth effectively could lead us to over-invest or under-invest in technology
  and operations; result in weaknesses in our infrastructure, systems, or controls; give rise to operational mistakes, losses, or
  loss of productivity or business opportunities; reduce client or user satisfaction; limit our ability to respond to competitive
  pressures; and could also result in loss of employees and reduced productivity of remaining employees. Our growth could require
  significant capital expenditures and may divert financial resources and management attention from other projects, such as the
  development of new or enhanced services. If our management is unable to effectively manage our growth, our expenses may increase
  more than expected, our revenue could decline or may grow more slowly than expected, and we may be unable to implement our business
  strategy</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 14; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may be unable to adequately protect, and we may incur significant costs in enforcing, our intellectual property and other proprietary
  rights.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  success depends in part on our ability to enforce our intellectual property and other proprietary rights. We expect to rely upon
  a combination of copyright, trademark, trade secret, and unfair competition laws, as well as license and access agreements and
  other contractual provisions, to protect these rights.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  attempts to protect our intellectual property through copyright, patent, and trademark registration may be challenged by others
  or invalidated through administrative process or litigation. While we intend to submit patent applications covering our integrated
  technology during 2017, the scope of issued patents, if any, may be insufficient to prevent competitors from providing products
  and services similar to ours, our patents may be successfully challenged, and we may not be able to obtain additional meaningful
  patent protection in the future. There can be no assurance that our patent registration efforts will be successful.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  expected agreements with clients, users, vendors and strategic partners will limit their use of, and allow us to retain our rights
  in, our intellectual property and proprietary information. Further, we anticipate that these agreements will grant us ownership
  of intellectual property created in the performance of those agreements to the extent that it relates to the provision of our
  services. In addition, we require certain of our employees and consultants to enter into confidentiality, non-competition, and
  assignment of inventions agreements. We also require certain of our vendors and strategic partners to agree to contract provisions
  regarding confidentiality and non-competition. However, no assurance can be given that these agreements will not be breached,
  and we may not have adequate remedies for any such breach. Further, no assurance can be given that these agreements will be effective
  in preventing the unauthorized access to, or use of, our proprietary information or the reverse engineering of our technology.
  Agreement terms that address non-competition are difficult to enforce in many jurisdictions and may not be enforceable in any
  particular case. In any event, these agreements do not prevent our competitors from independently developing technology or authoring
  clinical information that is substantially equivalent or superior to our technology or the information we distribute.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
  the extent that our intellectual property and other proprietary rights are not adequately protected, third parties might gain
  access to our proprietary information, develop and market products or services similar to ours, or use trademarks similar to ours,
  each of which could materially harm our business. Existing U.S. federal and state intellectual property laws offer only limited
  protection. In addition, if we resort to legal proceedings to enforce our intellectual property rights or to determine the validity
  and scope of the intellectual property or other proprietary rights of others, the proceedings could be burdensome and expensive,
  even if we were to prevail. Any litigation that may be necessary in the future could result in substantial costs and diversion
  of resources and could have a material adverse effect on our business, operating results, or financial condition.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
  addition, our platforms incorporate &ldquo;open source&rdquo; software components that are licensed to us under various public
  domain licenses. While we believe that we have complied with our obligations under the various applicable licenses for open source
  software that we use, open source license terms are often ambiguous, and there is little or no legal precedent governing the interpretation
  of many of the terms of certain of these licenses. Therefore, the potential impact of such terms on our business is somewhat unknown.
  For example, some open source licenses require that those using the associated code disclose modifications made to that code and
  such modifications be licensed to third parties at no cost. We monitor our use of open source software in an effort to avoid uses
  in a manner that would require us to disclose or grant licenses under our proprietary source code. However, there can be no assurance
  that such efforts will be successful, and such use could inadvertently occur.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I></I></B></FONT></P>
  
  <!-- Field: Page; Sequence: 15; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may be sued by third parties for alleged infringement of their proprietary rights.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  software and Internet industries are characterized by the existence of a large number of patents, trademarks, and copyrights and
  by frequent litigation based on allegations of infringement or other violations of intellectual property rights. We may receive
  in the future communications from third parties claiming that we, our technology, or components thereof, infringe on the intellectual
  property rights of others. We may not be able to withstand such third-party claims against our technology, and we could lose the
  right to use third-party technologies that are the subject of such claims. Any intellectual property claims, whether with or without
  merit, could be time-consuming and expensive to resolve, divert management attention from executing our business plan, and require
  us to pay monetary damages or enter into royalty or licensing agreements. Although we intend that many of our third-party service
  providers will be obligated to indemnify us if their products infringe the rights of others, such indemnification may not be effective
  or adequate to protect us or the indemnifying party may be unable to uphold its contractual obligations.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Moreover,
  any settlement or adverse judgment resulting from such a claim could require us to pay substantial amounts of money or obtain
  a license to continue to use the technology or information that is the subject of the claim, or otherwise restrict or prohibit
  our use of the technology or information. There can be no assurance that we would be able to obtain a license on commercially
  reasonable terms, if at all, from third parties asserting an infringement claim; that we would be able to develop alternative
  technology on a timely basis, if at all; that we would be able to obtain a license to use a suitable alternative technology or
  information to permit us to continue offering, and our clients to continue using, our affected services; or that we would not
  need to change our product and design plans, which could require us to redesign affected products or services or delay new offerings.
  Accordingly, an adverse determination could prevent us from implementing our strategy or offering our services and products, as
  currently contemplated.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may not be able to properly safeguard the information on the HealthLynked Network.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Information
  security risks have generally increased in recent years because of new technologies and the increased activities of perpetrators
  of cyber-attacks resulting in the theft of protected health, business or financial information. A failure in, or a breach of our
  information systems as a result of cyber attacks could disrupt our business, result in the release or misuse of confidential or
  proprietary information, damage our reputation, and increase our administrative expenses. Although we plan to have robust information
  security procedures and other safeguards in place, as cyber threats continue to evolve, we may be required to expend additional
  resources to continue to enhance our information security measures or to investigate and remediate any information security vulnerabilities.
  Any of these disruptions or breaches of security could have a material adverse effect on our business, financial condition and
  results of operations.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
  employees may not take all appropriate measures to secure and protect confidential information in their possession.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
  of our employees is advised that they are responsible for the security of the information in our systems and to ensure that private
  information is kept confidential. Should an employee not follow appropriate security measures, including those that have been
  put in place to prevent cyber threats or attacks, the improper release of protected health information could result. The release
  of such information could have a material adverse effect our reputation and our business, financial condition, results of operations
  and cash flows.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 16; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RISKS
  RELATED TO THE PROVISION OF MEDICAL SERVICES BY NWC</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Continuing
  unfavorable economic conditions could have an adverse effect on our business.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
  economic conditions in the United States have gradually improved, the number of unemployed and under-employed workers remains
  significant and economic growth has been slow. The percentage of our patient services provided through NWC that are being reimbursed
  under government-sponsored healthcare programs could increase if economic conditions do not improve or if they deteriorate and
  possibly lower patient volumes. These conditions could also lead to additional increases in the number of unemployed and under-employed
  workers and a decline in the number of private employers that offer healthcare insurance coverage to their employees. Employers
  that do offer healthcare coverage may increase the required contributions from employees to pay for their coverage and increase
  patient responsibility amounts. As a consequence, the number of patients who participate in government-sponsored programs or are
  uninsured could increase. In addition, due to the rising costs of managed care premiums and patient responsibility amounts, coupled
  with the current economic environment, NWC may experience increased bad debt due to patients&rsquo; inability to pay for certain
  services. Further, it is too early to determine whether the Affordable Care Act will increase or decrease the number of our patients
  with private healthcare insurance, obtained either through employers or the recently established insurance exchanges. Payments
  received from government-sponsored programs are substantially less than payments received from private healthcare insurance programs
  (managed care and other third-party payors). In addition, payments under the recently established health care exchanges may be
  less than payments from private healthcare insurance programs. A payor mix shift from private healthcare insurance programs to
  government payors may result in an increase in NWC&rsquo;s estimated provision for contractual adjustments and uncollectible amounts
  and a corresponding decrease in our net patient service revenue. Further increases in the government component of our payor mix
  at the expense of other third-party payors could result in a significant reduction in our average reimbursement rates.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Any
  state budgetary constraints could have an adverse effect on our reimbursement from Medicaid programs</I></B><I>.</I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
  a result of slow economic growth and volatile economic conditions, many states are continuing to collect less revenue than they
  did in prior years and as a consequence are facing budget shortfalls and underfunded pension and other obligations. Although the
  shortfalls for the more recent budgetary years have declined, they are still significant by historical standards. The financial
  condition in Florida or other states in which we may in the future could lead to reduced or delayed funding for Medicaid programs
  and, in turn, reduced or delayed reimbursement for physician services, which could adversely affect our results of operations,
  cash flows and financial condition.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
  Affordable Care Act may have a significant effect on our business.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Affordable Care Act contains a number of provisions that could affect us over the next several years. These provisions include
  the establishment of health insurance exchanges to facilitate the purchase of qualified health plans, expanding Medicaid eligibility,
  subsidizing insurance premiums and creating requirements and incentives for businesses to provide healthcare benefits. Other provisions
  contain changes to healthcare fraud and abuse laws and expand the scope of the FCA.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Affordable Care Act contains numerous other measures that could affect us. For example, payment modifiers are being developed
  that will differentiate payments to physicians under federal healthcare programs based on quality and cost of care. In addition,
  other provisions authorize voluntary demonstration projects relating to the bundling of payments for episodes of hospital care
  and the sharing of cost savings achieved under the Medicare program.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Centers for Medicare and Medicaid Services (&ldquo;CMS&rdquo;) issued a final rule under the Affordable Care Act that is intended
  to allow physicians, hospitals and other health care providers to coordinate care for Medicare beneficiaries through Accountable
  Care Organizations (&ldquo;ACOs&rdquo;). ACOs are entities consisting of healthcare providers and suppliers organized to deliver
  services to Medicare beneficiaries and eligible to receive a share of any cost savings the entity can achieve by delivering services
  to those beneficiaries at a cost below a set baseline and based upon established quality of care standards. We will continue to
  evaluate the impact of the ACO regulations on our business and operations.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Many
  of the Affordable Care Act&rsquo;s most significant reforms, such as the establishment of state-based and federally facilitated
  insurance exchanges that provide a marketplace for eligible individuals and small employers to purchase health care insurance,
  became effective relatively recently. On October 1, 2013, individuals began enrolling in health care insurance plans offered under
  these state-based and federally-facilitated insurance exchanges, notwithstanding significant technical issues in accessing and
  enrolling in the federal online exchange. Such issues may have delayed or reduced the purchase of health care insurance by uninsured
  persons. In order to be covered on the effective date of January 1, 2014 individuals were required to enroll and pay their first
  premium by December 24, 2013, however, extensions have been, and may continue to be granted on a case by case basis depending
  on specific circumstances. Uninsured persons who do not enroll in health care insurance plans by March 31, 2014 will be required
  to pay a penalty to the Internal Revenue Service, unless a hardship exception applies. The patient responsibility costs related
  to health care plans obtained through the insurance exchanges may be high, and we may experience increased bad debt due to NWC&rsquo;s
  patients&rsquo; inability to pay for certain services.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 17; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Affordable Care Act also allows states to expand their Medicaid programs through an increase in the Medicaid eligibility income
  limit from a state&rsquo;s current eligibility levels to 133% of the federal poverty level. It remains unclear to what extent
  states will expand their Medicaid programs by raising the income limit to 133% of the federal poverty level. As a result of these
  and other uncertainties, we cannot predict whether there will be more uninsured patients in 2014 than anticipated when the Affordable
  Care Act was enacted.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Affordable Care Act also remains subject to continuing legislative scrutiny, including efforts by Congress to amend or repeal
  a number of its provisions as well as administrative actions delaying the effectiveness of key provisions. As a result, we cannot
  predict with any assurance the ultimate effect of the Affordable Care Act on our Company, nor can we provide any assurance that
  its provisions will not have a material adverse effect on our business, financial condition, results of operations or cash flows.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Government-funded
  programs or private insurers may limit, reduce or make retroactive adjustments to reimbursement amounts or rates.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
  portion of the net patient service revenue derived from services rendered through NWC is from payments made by Medicare and Medicaid
  <FONT STYLE="background-color: white">and other government-sponsored or funded healthcare programs (the &ldquo;GHC Programs&rdquo;)</FONT>.
  These government-funded programs, as well as private insurers, have taken and may continue to take steps, including a movement
  toward increased use of managed care organizations, value-based purchasing, and new patient care models to control the cost, eligibility
  for, use and delivery of healthcare services as a result of budgetary constraints and cost containment pressures due to unfavorable
  economic conditions, rising healthcare costs and for other reasons. These government-funded programs and private insurers may
  attempt other measures to control costs, including bundling of services and denial of, or reduction in, reimbursement for certain
  services and treatments. As a result, payments from government programs or private payors may decrease significantly. Also, any
  adjustment in Medicare reimbursement rates may have a detrimental impact on our reimbursement rates not only for Medicare patients,
  but also because Medicaid and other third-party payors often base their reimbursement rates on a percentage of Medicare rates.
  Our business may also be materially affected by limitations on, or reductions in, reimbursement amounts or rates or elimination
  of coverage for certain individuals or treatments. Moreover, because government-funded programs generally provide for reimbursements
  on a fee-schedule basis rather than on a charge-related basis, we generally cannot increase our revenues from these programs by
  increasing the amount we charge for services rendered by NWC&rsquo;s physicians. To the extent our costs increase, we may not
  be able to recover our increased costs from these programs, and cost containment measures and market changes in non-government-funded
  insurance plans have generally restricted our ability to recover, or shift to non-governmental payors, these increased costs.
  In addition, funds we receive from third-party payors are subject to audit with respect to the proper billing for physician and
  ancillary services and, accordingly, our revenue from these programs may be adjusted retroactively. Any retroactive adjustments
  to our reimbursement amounts could have a material effect on our financial condition, results of operations, cash flows and the
  trading price of our common stock.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may become subject to billing investigations by federal and state government authorities.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Federal
  and state laws, rules and regulations impose substantial penalties, including criminal and civil fines, exclusion from participation
  in government healthcare programs and imprisonment, on entities or individuals (including any individual corporate officers or
  physicians deemed responsible) that fraudulently or wrongfully bill government-funded programs or other third-party payors for
  healthcare services. CMS issued a final rule requiring states to implement a Medicaid Recovery Audit Contractor (&ldquo;RAC&rdquo;)
  program effective January 1, 2012. States are required to contract with one or more eligible Medicaid RACs to review Medicaid
  claims for any overpayments or underpayments, and to recoup overpayments from providers on behalf of the state. In addition, federal
  laws, along with a growing number of state laws, allow a private person to bring a civil action in the name of the government
  for false billing violations. We believe that audits, inquiries and investigations from government agencies will occur from time
  to time in the ordinary course of NWC&rsquo;s operations, which could result in substantial defense costs to us and a diversion
  of management&rsquo;s time and attention. We cannot predict whether any future audits, inquiries or investigations, or the public
  disclosure of such matters, would have a material adverse effect on our business, financial condition, results of operations,
  cash flows and the trading price of our common stock.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I></I></B></FONT></P>
  
  <!-- Field: Page; Sequence: 18; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may not appropriately record or document the services provided by our physicians.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  must appropriately record and document the services our doctors provide to seek reimbursement for their services from third-party
  payors. If our physicians do not appropriately document, or where applicable, code for their services, we could be subjected to
  administrative, regulatory, civil, or criminal investigations or sanctions and our business, financial condition, results of operations
  and cash flows could be adversely affected.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may not be able to successfully recruit and retain qualified physicians, who are key to NWC&rsquo;s revenues and billing<FONT STYLE="background-color: white">.</FONT></I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
  part of our business plan, we may acquire other medical practices as we see fit to further develop, test and deploy the HealthLynked
  Network into new strategic regional areas throughout the country. We compete with many types of healthcare providers, including
  teaching, research and government institutions, hospitals and health systems and other practice groups, for the services of qualified
  doctors. We may not be able to continue to recruit new physicians or renew contracts with existing physicians on acceptable terms.
  If we do not do so, our ability to service execute our business plan may be adversely affected. Our founder, Dr. Michael Dent,
  retired in 2016 from seeing patients. We are in the process of replacing him with an experienced physician who is qualified to
  perform surgeries. If we are unable to replace Dr. Dent, or to find a physician who can perform the same types of procedures,
  including surgeries, it could have a material adverse effect on the operations of NWC. Patient service revenue decreased by $592,068,
  or 23%, from the year ended December 31, 2015 to 2016, and by $37,449, or 7%, from the three months ended March 31, 2016 to the
  same period of 2017, primarily as a result of Dr. Dent&rsquo;s retirement in February 2016 and a decrease in production by the
  physician staff, resulting in a decrease in gross billings of approximately 16% from the year ended December 31, 2015 to 2016
  and 5% from the three months ended March 31, 2016 to the same period of 2017.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>A
  significant number of NWC physicians could leave our practice and we may be unable to enforce the non-competition covenants of
  departed employees.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  have entered into employment agreements with the current NWC physicians. Certain of our employment agreements can be terminated
  without cause by any party upon prior written notice. In addition, substantially all of our physicians have agreed not to compete
  with us within a specified geographic area for a certain period after termination of employment. The law governing non-compete
  agreements and other forms of restrictive covenants varies from state to state. Although we believe that the non-competition and
  other restrictive covenants applicable to our affiliated physicians are reasonable in scope and duration and therefore enforceable
  under applicable state law, courts and arbitrators in some states are reluctant to strictly enforce non-compete agreements and
  restrictive covenants against physicians. Our physicians may leave our practices for a variety of reasons, including providing
  services for other types of healthcare providers, such as teaching, research and government institutions, hospitals and health
  systems and other practice groups. If a substantial number of our physicians leave our practices or we are unable to enforce the
  non-competition covenants in the employment agreements, our business, financial condition, results of operations and cash flows
  could be materially, and adversely affected. We cannot predict whether a court or arbitration panel would enforce these covenants
  in any particular case.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may be subject to medical malpractice and other lawsuits not covered by insurance.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  business entails an inherent risk of claims of medical malpractice against our affiliated physicians and us. We may also be subject
  to other lawsuits which may involve large claims and significant defense costs. Although we currently maintain liability insurance
  coverage intended to cover professional liability and other claims, there can be no assurance that our insurance coverage will
  be adequate to cover liabilities arising out of claims asserted against us. Liabilities in excess of our insurance coverage, including
  coverage for professional liability and other claims, could have a material adverse effect on our business, financial condition,
  results of operations, cash flows and the trading price of our common stock. See &ldquo;Description of Our Business-Professional
  and General Liability Coverage.&rdquo;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I></I></B></FONT></P>
  
  <!-- Field: Page; Sequence: 19; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may not be able to collect reimbursements for our services from third-party payors in a timely manner.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
  significant portion of our net patient service revenue is derived from reimbursements from various third-party payors, including
  <FONT STYLE="background-color: white">GHC Programs</FONT>, private insurance plans and managed care plans, for services provided
  by NWC physicians. We are responsible for submitting reimbursement requests to these payors and collecting the reimbursements,
  and we assume the financial risks relating to uncollectible and delayed reimbursements. In the current healthcare environment,
  payors continue their efforts to control expenditures for healthcare, including revisions to coverage and reimbursement policies.
  Due to the nature of our business and our participation in government-funded and private reimbursement programs, we are involved
  from time to time in inquiries, reviews, audits and investigations by governmental agencies and private payors of our business
  practices, including assessments of our compliance with coding, billing and documentation requirements. We may be required to
  repay these agencies or private payors if a finding is made that we were incorrectly reimbursed, or we may be subjected to pre-payment
  reviews, which can be time-consuming and result in non-payment or delayed payment for the services we provide. We may also experience
  difficulties in collecting reimbursements because third-party payors may seek to reduce or delay reimbursements to which we are
  entitled for services that our affiliated physicians have provided. In addition, GHC Programs may deny our application to become
  a participating provider that could prevent us from providing services to patients or prohibit us from billing for such services.
  If we are not reimbursed fully and in a timely manner for such services or there is a finding that we were incorrectly reimbursed,
  our revenue, cash flows and financial condition could be materially, adversely affected.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Certain
  federal and state laws may limit our effectiveness at collecting monies owed to us from patients.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  utilize third parties to collect from patients any co-payments and other payments for services that are provided by NWC physicians.
  The federal Fair Debt Collection Practices Act restricts the methods that third-party collection companies may use to contact
  and seek payment from consumer debtors regarding past due accounts. State laws vary with respect to debt collection practices,
  although most state requirements are similar to those under the Fair Debt Collection Practices Act. T<FONT STYLE="background-color: white">he
  Florida Consumer Collection Practices Act, is broader than the federal legislation, applying the regulations to &ldquo;creditors&rdquo;
  as well as &ldquo;collectors,&rdquo; whereas the </FONT>Fair Debt Collection Practices Act <FONT STYLE="background-color: white">is
  applicable only to collectors. This prohibits creditors who are attempting to collect their own debts from engaging in behavior
  prohibited by the </FONT>Fair Debt Collection Practices Act <FONT STYLE="background-color: white">and Florida Consumer Collection
  Practices Act. The Act has very specific guidelines regarding which actions debt collectors and creditors may engage in to collect
  unpaid debt.</FONT> If our collection practices or those of our collection agencies are inconsistent with these standards, we
  may be subject to actual damages and penalties. These factors and events could have a material adverse effect on our business,
  financial condition and results of operations.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
  may not be able to maintain effective and efficient information systems.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  profitability of our business, including the services provided by NWC, is dependent on uninterrupted performance of our information
  systems. Failure to maintain reliable information systems, disruptions in our existing information systems or the implementation
  of new systems could cause disruptions in our business operations, including errors and delays in billings and collections, disputes
  with patients and payors, violations of patient privacy and confidentiality requirements and other regulatory requirements, increased
  administrative expenses and other adverse consequences.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RISKS
  RELATING TO OUR ORGANIZATION</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
  articles of incorporation authorize our board to create a new series of preferred stock without further approval by our stockholders,
  which could adversely affect the rights of the holders of our common stock.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  board of directors has the authority to fix and determine the relative rights and preferences of preferred stock. Our board of
  directors also has the authority to issue preferred stock without further stockholder approval. As a result, our board of directors
  could authorize the issuance of a series of preferred stock that would grant to holders the preferred right to our assets upon
  liquidation, the right to receive dividend payments before dividends are distributed to the holders of common stock and the right
  to the redemption of the shares, together with a premium, prior to the redemption of our common stock. In addition, our board
  of directors could authorize the issuance of a series of preferred stock that has greater voting power than our common stock or
  that is convertible into our common stock, which could decrease the relative voting power of our common stock or result in dilution
  to our existing stockholders.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 20; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Stockholders&rsquo;
  ability to influence corporate decisions may be limited because Michael Dent, our Chief Executive Officer and Chairman of the
  Board, currently owns a controlling percentage of our common stock.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Currently,
  Dr. Dent, our Chief Executive Officer and Chairman of the Board, beneficially owns approximately 72.39% of our outstanding common
  stock. As a result of this stock ownership, Dr. Dent can control all matters submitted to our stockholders for approval, including
  the election of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. This concentration
  of voting power could delay or prevent an acquisition of our company on terms that other stockholders may desire. In addition,
  as the interests of Dr. Dent and our minority stockholders may not always be the same, this large concentration of voting power
  may lead to stockholder votes that are inconsistent with the best interests of our minority stockholders or the best interest
  of the Company as a whole.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
  we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results
  accurately or to prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation
  and adversely impact the trading price of our common stock.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effective
  internal control is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable financial
  reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment
  existed, and our business and reputation with investors may be harmed. As a result, our small size and any current internal control
  deficiencies may adversely affect our financial condition, results of operation and access to capital. We have not performed an
  in-depth analysis to determine if historical un-discovered failures of internal controls exist, and may in the future discover
  areas of our internal control that need improvement.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  are required to comply with the Commission&rsquo;s rules implementing Section 302 of the Sarbanes-Oxley Act of 2002, which require
  our management to certify financial and other information in our quarterly and annual reports and provide an annual management
  report on the effectiveness of our internal control over financial reporting. However, we will not be required to make our first
  assessment of our internal control over financial reporting until the year following our first annual report required to be filed
  with the Commission. To comply with the requirements of being a public company, we will need to implement additional financial
  and management controls, reporting systems and procedures and hire accounting, finance and legal staff.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Further,
  our independent registered public accounting firm is not yet required to formally attest to the effectiveness of our internal
  controls over financial reporting, and will not be required to do so for as long as we are an &ldquo;emerging growth company&rdquo;
  pursuant to the provisions of the JOBS Act. Please read &ldquo;Summary&mdash;Emerging Growth Company Status.&rdquo;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Public
  company compliance may make it more difficult to attract and retain officers and directors.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Sarbanes-Oxley Act and new rules subsequently implemented by the Commission have required changes in corporate governance practices
  of public companies. As a public company, we expect these new rules and regulations to increase our compliance costs and to make
  certain activities more time consuming and costly. As a public company, we also expect that these new rules and regulations may
  make it more difficult and expensive for us to obtain director and officer liability insurance in the future and we may be required
  to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a
  result, it may be more difficult for us to attract and retain qualified persons to serve on our board of directors or as executive
  officers.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
  public market for our common stock is new and extremely limited.&nbsp;&nbsp;Failure to develop or maintain a trading market could
  negatively affect its value and make it difficult or impossible for you to sell your shares.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  common stock has traded on the OTCQB under the symbol &ldquo;HLYK&rdquo; since May 10, 2017.&nbsp;&nbsp;There is a limited public
  market for our common stock and an active public market for our common stock may not develop.&nbsp;&nbsp;Failure to develop or
  maintain an active trading market could make it difficult for you to sell your shares or recover any part of your investment in
  us.&nbsp;&nbsp;Even if a market for our common stock does develop, the market price of our common stock may be highly volatile.&nbsp;&nbsp;In
  addition to the uncertainties relating to future operating performance and the profitability of operations, factors such as variations
  in interim financial results or various, as yet unpredictable, factors, many of which are beyond our control, may have a negative
  effect on the market price of our common stock.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 21; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
  common stock is subject to the &ldquo;penny stock&rdquo; rules of the Commission and the trading market in the securities is limited,
  which makes transactions in our common stock cumbersome and may reduce the value of an investment in our common stock.</I></B>&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Rule
  15g-9 under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) establishes the definition of a &ldquo;penny
  stock,&rdquo; for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or
  with an exercise price of less than $5.00 per share, subject to certain exceptions. &nbsp;For any transaction involving a penny
  stock, unless exempt, the rules require: (a) that a broker or dealer approve a person&rsquo;s account for transactions in penny
  stocks; and (b) the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity
  and quantity of the penny stock to be purchased.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
  order to approve a person&rsquo;s account for transactions in penny stocks, the broker or dealer must: (a) obtain financial information
  and investment experience objectives of the person and (b) make a reasonable determination that the transactions in penny stocks
  are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating
  the risks of transactions in penny stocks.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the Commission
  relating to the penny stock market, which, in highlight form: (a) sets forth the basis on which the broker or dealer made the
  suitability determination; and (b) confirms that the broker or dealer received a signed, written agreement from the investor prior
  to the transaction. &nbsp;Generally, brokers may be less willing to execute transactions in securities subject to the &ldquo;penny
  stock&rdquo; rules. &nbsp;This may make it more difficult for investors to dispose of our Common Stock and cause a decline in
  the market value of our Common Stock.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Disclosure
  also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the
  commissions payable to both the broker or dealer and the registered representative, current quotations for the securities and
  the rights and remedies available to an investor in cases of fraud in penny stock transactions. &nbsp;Finally, monthly statements
  have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market
  in penny stocks.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;Offers
  or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
  our stockholders sell substantial amounts of our common stock in the public market, including upon the expiration of any statutory
  holding period under Rule 144 or registration for resale, or issued upon the conversion of convertible notes, or exercise of warrants,
  it could create a circumstance commonly referred to as an &ldquo;overhang&rdquo; and in anticipation of which the market price of
  our common stock could fall.&nbsp;&nbsp;As of the date of this prospectus, we currently have 7,375,000 shares underlying convertible
  notes that have been registered for resale pursuant to an effective registration statement on Form S-1 (File No. 333-215963),
  up to $3,000,000 worth of shares that have been registered for resale pursuant to an effective registration statement on Form
  S-1 (File No, 333-217309) and 3,517,496 shares of common stock that we are registering for resale pursuant to this reoffer prospectus.
  The existence of an overhang, whether or not sales have occurred or are occurring, also could make more difficult our ability
  to raise additional financing through the sale of equity or equity-related securities in the future at a time and price that we
  deem reasonable or appropriate.&nbsp;&nbsp;Further, a substantial number of shares of common stock are being offered by this prospectus,
  and we cannot predict if and when the purchasers may sell such shares in the public markets. In addition, we cannot predict the
  number of these shares that might be sold nor the effect that future sales of our shares of common stock would have on the market
  price of our shares of common stock.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 22; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Drawdowns
  under the Investment Agreement may cause dilution to existing shareholders.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Iconic,
  our counterparty in the Investment Agreement, has committed to purchase up to $3,000,000 worth of shares of our common stock.
  From time to time during the term of the Investment Agreement, and at our sole discretion, we may present Iconic with a put notice
  requiring Iconic to purchase shares of our common stock. The purchase price to be paid by Iconic will be 80% of the lowest volume
  weighted average price of our common stock during the five consecutive trading days prior to the date on which written notice
  is sent by us to the investor stating the number of shares that the Company is selling to the investor, subject to certain adjustments.
  As a result, our existing shareholders will experience immediate dilution upon the purchase of any of the shares by Iconic. The
  issue and sale of the shares under the Investment Agreement may also have an adverse effect on the market price of the common
  shares. Iconic may resell some, if not all, of the shares that we issue to it under the Investment Agreement and such sales could
  cause the market price of the common stock to decline significantly. To the extent of any such decline, any subsequent puts would
  require us to issue and sell a greater number of shares to Iconic in exchange for each dollar of the put amount. Under these circumstances,
  the existing shareholders of our company will experience greater dilution. The effect of this dilution may, in turn, cause the
  price of our common stock to decrease further, both because of the downward pressure on the stock price that would be caused by
  a large number of sales of our shares into the public market by Iconic, and because our existing stockholders may disagree with
  a decision to sell shares to Iconic at a time when our stock price is low, and may in response decide to sell additional shares,
  further decreasing our stock price. If we draw down amounts under the Investment Agreement when our share price is decreasing,
  we will need to issue more shares to raise the same amount of funding.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 8.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Certain
  restrictions on the extent of puts and the delivery of advance notices may have little, if any, effect on the adverse impact of
  our issuance of shares in connection with the Investment Agreement and as such, Iconic may sell a large number of shares, resulting
  in substantial dilution to the value of shares held by existing stockholders.</I></B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Iconic
  has agreed, subject to certain exceptions listed in the investment agreement with Iconic, to refrain from holding an amount of
  shares which would result in Iconic or its affiliates owning more than 9.99% of the then-outstanding shares of our common stock
  at any one time. These restrictions, however, do not prevent Iconic from selling shares of our common stock received in connection
  with a put, and then receiving additional shares of our common stock in connection with a subsequent put. In this way, Iconic
  could sell more than 9.99% of the outstanding common stock in a relatively short time frame while never holding more than 9.99%
  at one time.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 8.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  
  <!-- Field: Page; Sequence: 23; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a4"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>USE
  OF PROCEEDS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  shares which may be sold under this reoffer prospectus will be sold for the respective accounts of each of the Selling Securityholders
  listed herein (which includes our executive officers and directors). Accordingly, we will not realize any proceeds from the sale
  of the shares of our common stock. We will receive proceeds from the exercise of the options; however, no assurance can be given
  as to when or if any or all of the options will be exercised. If any options are exercised, the proceeds derived therefrom will
  be used for working capital and general corporate purposes. All expenses of the registration of the shares will be paid by us.
  See &ldquo;Selling Securityholders&rdquo; and &ldquo;Plan of Distribution.&rdquo;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  
  <!-- Field: Page; Sequence: 24; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a5"></A>SELLING
  SECURITYHOLDERS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  are registering for resale the shares covered by this prospectus to permit the Selling Securityholders identified below and their
  pledgees, donees, transferees and other successors-in-interest that receive their securities from a Selling Securityholder as
  a gift, partnership distribution or other non-sale related transfer after the date of this prospectus to resell the shares when
  and as they deem appropriate. The Selling Securityholders acquired, or may acquire, these shares from us pursuant to the Plan.
  The shares may not be sold or otherwise transferred by the Selling Securityholders unless and until the applicable awards vest
  and are exercised, as applicable, in accordance with the terms and conditions of the Plan. The amount of shares to be reoffered
  or resold by means of this prospectus by each Selling Securityholder, and any other person with whom such Selling Securityholder
  is acting in concert for the purpose of selling our securities, may not exceed, during any three-month period, the amount specified
  in Rule 144(e) of the Securities Act. Although a person&rsquo;s name is included in the table below, neither that person nor we
  are making an admission that the named person is our &ldquo;affiliate.&rdquo;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  following table sets forth:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
      name of each Selling Securityholder;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
      position(s), office or other material relationship with our company and its predecessors or affiliates, over the last three
      years of each Selling Securityholder;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
      number and percentage of shares of our common stock that each Selling Securityholder beneficially owned as of May 19, 2017
      prior to the offering for resale of the shares under this prospectus;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
      number of shares of our common stock that may be offered for resale for the account of each Selling Securityholder under this
      prospectus; and</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
      number and percentage of shares of our common stock to be beneficially owned by each Selling Securityholder after the offering
      of the resale shares (assuming all of the offered resale shares are sold by such Selling Securityholder).</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Information
  with respect to beneficial ownership is based upon information obtained from the Selling Securityholders.&nbsp;&nbsp;Because the
  Selling Securityholders may offer all or part of the shares of common stock, which they own pursuant to the offering contemplated
  by this reoffer prospectus, and because its offering is not being underwritten on a firm commitment basis, no estimate can be
  given as to the amount of shares that will be held upon termination of this offering.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  
  <!-- Field: Page; Sequence: 25; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  number of shares in the column &rsquo;&lsquo;Number of Shares Being Offered&rsquo;&rsquo; represents all of the shares of our
  common stock that each Selling Securityholder may offer under this prospectus. We do not know how long the Selling Securityholders
  will hold the shares before selling them or how many shares they will sell. The shares of our common stock offered by this prospectus
  may be offered from time to time by the Selling Securityholders listed below. We cannot assure you that any of the Selling Securityholders
  will offer for sale or sell any or all of the shares of common stock offered by them by this prospectus.</FONT></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares Beneficially Owned Prior to Offering (1)</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares Beneficially Owned After Offering (2)</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">Securityholders</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Position</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Percent (%)</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Being Offered</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Percent (%)</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif; text-align: left">Michael T. Dent (3)</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Executive Officer and Chairman</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right">52,053,640</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right">72.39</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,000,000</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font: 10pt Times New Roman, Times, Serif; text-align: right">51,853,640</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font: 10pt Times New Roman, Times, Serif; text-align: right">72.32</TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">George O&rsquo;Leary (4)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Financial Officer and Director</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,300,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3.29</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">600,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,100,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3.01</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Robert Horel (5)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Marketing Officer</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">449,996</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Carolyn Monaco (6)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,312,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4.75</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">212,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,100,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4.45</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Cindy Troy (7)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">322,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">262,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">60,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jennie Sanderson (8)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">207,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">147,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">60,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Kara Brogan (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">122,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">122,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Leila Sakhai (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">102,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">102,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jean Burton (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">102,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">102,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Terri Caton (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Former employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Katherine Zea (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">47,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">47,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Mary Cooper (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">47,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">47,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Laurie Whitt (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Wendy Pulver (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Dana Howell (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Former employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">42,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">42,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Sherry Terlecki (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Erin Adams (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Anilegna Betancourt (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Maricet Camuzo (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Isabel Castro (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Melissa Kopczynski (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Eileen Clark (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Kelly Tyson (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Doug Charles (9)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current employee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">---</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>
  
  
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">**&nbsp;&nbsp;less
  than 1%</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 0px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Exchange Act, and the
      information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, beneficial ownership
      includes any shares as to which the Selling Securityholder has sole or shared voting power or investment power and also any
      shares which the Selling Securityholder has the right to acquire within 60 days. Applicable percentage ownership is based
      on 69,703,640 shares of common stock outstanding as of May 19, 2017.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
      that all shares of common stock to be offered, as set forth above, are sold pursuant to this offering and that no other shares
      of common stock are acquired or disposed of by the Selling Securityholders prior to the termination of this offering. Because
      the Selling Securityholders may sell all, some or none of their shares of common stock or may acquire or dispose of other
      shares of common stock, no reliable estimate can be made of the aggregate number of shares of common stock that will be sold
      pursuant to this offering or the number or percentage of shares of common stock that each Selling Securityholder will own
      upon completion of this offering.</FONT></TD></TR>
  </TABLE>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Page; Sequence: 26; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
      ownership prior to the offering includes 2,953,640 shares of common stock held by Dr. Dent directly, 46,900,000 shares of
      common stock held in the name of Mary S. Dent Gifting Trust Common, 2,000,000 shares of common stock issuable upon exercise
      of warrants with an exercise price of $0.05 and 200,000 shares issuable upon exercise of vested employee stock options with
      an exercise price of $0.08. Excludes 800,000 shares issuable upon exercise of employee stock options with an exercise price
      of $0.08 which are subject to future vesting requirements and are not expected to vest within 60 days of May 19, 2017.&nbsp;&nbsp;Shares
      being offered includes 1,000,000 shares of common stock issuable upon exercise of stock options.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
      ownership prior to the offering includes 2,100,000 shares of common stock held by SKS Consulting of South Florida Corp., a
      corporation directly controlled by George O&rsquo;Leary and 200,000 shares issuable upon exercise of vested employee stock
      options with an exercise price of $0.08 held by George O&rsquo;Leary directly. Excludes shares issuable upon exercise of 400,000
      employee stock options held by George O&rsquo;Leary directly with an exercise price of $0.08 which are subject to future vesting
      requirements and are not expected to vest within 60 days of May 19, 2017.&nbsp;&nbsp;Shares being offered include all 600,000
      shares issuable upon exercise of employee stock options held by George O&rsquo;Leary directly.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
      ownership prior to the offering excludes 449,996 shares issuable upon exercise of employee stock options with an exercise
      price of $0.20 which are subject to future vesting requirements, none of which are vested or expected to vest within 60 days
      of May 19, 2017, and all of which are being offered hereunder.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
      ownership prior to the offering includes (i) 3,100,000 shares of common stock acquired by Carolyn Monaco in 2014 not being
      offered hereunder, and (ii) 212,500 shares of common stock issued under the Plan being offered hereunder.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
      ownership prior to the offering includes (i) 60,000 shares of common stock acquired by Cindy Troy in 2014 not being offered
      hereunder, and (ii) 262,500 shares of common stock issued under the Plan being offered hereunder.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
      ownership prior to the offering includes (i) 60,000 shares of common stock acquired by Jennie Sanderson in 2014 not being
      offered hereunder, and (ii) 147,500 shares of common stock issued under the Plan being offered hereunder.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
      shares of common stock issued under the Plan.</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  
  <!-- Field: Page; Sequence: 27; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a6"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PLAN
  OF DISTRIBUTION</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Selling Securityholders and any of their respective pledgees, donees, assignees and other successors-in-interest may, from time
  to time, sell any or all of their shares of our common stock on any stock exchange, market or trading facility on which the shares
  are traded or in private transactions. These sales may be at fixed or negotiated prices. The amount of shares to be reoffered
  or resold by means of this prospectus by each Selling Securityholder, and any other person with whom such Selling Securityholder
  is acting in concert for the purpose of selling our securities, may not exceed, during any three-month period, the amount specified
  in Rule&nbsp;144(e)&nbsp;of the Securities Act. The Selling Securityholders may use any one or more of the following methods when
  selling shares:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
      brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
      trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block
      as principal to facilitate the transaction;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
      by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
      exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
      negotiated transactions;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">short
      sales after this registration statement becomes effective;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers
      may agree with the Selling Securityholders to sell a specified number of such shares at a stipulated price per share;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
      the writing of options on the shares;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
      combination of any such methods of sale; and</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 48px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
      other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Selling Securityholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.
  The Selling Securityholders will have the sole and absolute discretion not to accept any purchase offer or make any sale of shares
  if they deem the purchase price to be unsatisfactory at any particular time.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Selling Securityholders may also engage in short sales against the box after this registration statement becomes effective, puts
  and calls and other transactions in our securities or derivatives of our securities and may sell or deliver shares in connection
  with these trades.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Selling Securityholders or their respective pledges, donees, transferees or other successors in interest, may also sell the shares
  directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers. Such
  broker-dealers may receive compensation in the form of discounts, concessions or commissions from the Selling Securityholders
  and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which
  compensation as to a particular broker-dealer might be in excess of customary commissions. Market makers and block purchasers
  purchasing the shares of common stock in block transactions to market makers or other purchasers at a price per share which may
  be below the then market price. The Selling Securityholders cannot assure that all or any of the shares offered in this prospectus
  will be issued to, or sold by, the Selling Securityholders. The Selling Securityholders and any brokers, dealers or agents, upon
  effecting the sale of any of the shares offered in this prospectus, may be deemed to be &rsquo;&lsquo;underwriters&rsquo;&rsquo;
  as that term is defined under the Securities Act or the Exchange Act, or the rules and regulations under such acts. In such event,
  any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be
  deemed to be underwriting commissions or discounts under the Securities Act.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 28; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Discounts,
  concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by the Selling
  Securityholders. The Selling Securityholders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions
  involving sales of the shares if liabilities are imposed on that person under the Securities Act.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Selling Securityholders may from time to time pledge or grant a security interest in some or all of the shares of common stock
  owned by them and, if they default in the performance of their secured obligations, the pledge or secured parties may offer and
  sell the shares of common stock from time to time under this prospectus after we have filed an amendment to this prospectus under
  Rule&nbsp;424(b)(3) or any other applicable provision of the Securities Act amending the list of Selling Securityholders to include
  the pledge, transferee or other successors in interest as Selling Securityholders under this prospectus.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  Selling Securityholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledges
  or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares
  of common stock from time to time under this prospectus after we have filed an amendment to this prospectus under Rule 424(b)(3)
  or other applicable provision of the Securities Act amending the list of Selling Securityholders to include the pledge, transferee
  or other successors in interest as Selling Securityholders under this prospectus.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
  of the Selling Securityholders acquired the securities offered hereby in the ordinary course of business and have advised us that
  they have not entered into any agreements, understandings or arrangements with any underwriters or broker-dealers regarding the
  sale of their shares of common stock, nor is there an underwriter or coordinating broker acting in connection with a proposed
  sale of shares of common stock by any Selling Securityholder. If we are notified by any Selling Securityholder that any material
  arrangement has been entered into with a broker-dealer for the sale of shares of common stock, if required, we will file a supplement
  to this prospectus. If the Selling Securityholders use this prospectus for any sale of the shares of common stock, they will be
  subject to the prospectus delivery requirements of the Securities Act.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of our common stock and activities of the Selling
  Securityholders.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  will bear all costs, expenses and fees in connection with the registration of the common stock offered hereby. However, the Selling
  Securityholders will bear any brokerage or underwriting commissions and similar selling expenses, if any, attributable to the
  sale of the shares of common stock offered pursuant to this reoffer prospectus. We have agreed to indemnify certain of the Selling
  Securityholders against certain liabilities, including liabilities under the Act, or to contribute to payments to which any of
  those security holders may be required to make in respect thereof.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
  can be no assurance that the Selling Securityholders will sell any or all of the securities offered by them hereby.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a7"></A>LEGAL
  MATTERS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  validity of the issuance of the securities offered by this prospectus will be passed upon for us by&nbsp;Sichenzia Ross Ference
  Kesner LLP, New York, New York.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a8"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EXPERTS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
  audited financial statements as of December 31, 2016 and 2015 have been included in this prospectus in reliance on the report
  of RBSM LLP, an independent registered public accounting firm appearing elsewhere herein given on the authority of said firm as
  experts in auditing and accounting.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 29; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a9"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>INCORPORATION
  OF CERTAIN DOCUMENTS BY REFERENCE</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  following documents, heretofore filed by us with the Commission pursuant to the Securities Act or the Exchange Act, are hereby
  incorporated by reference, except as superseded or modified herein:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Quarterly
                                           Report on Form 10-Q filed on May 15, 2017;</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
                                           Reports on Form&nbsp;8-K (excluding any reports or portions thereof that are deemed to
                                           be furnished and not filed) filed on May 16, 2017 and May 10, 2017;</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment
                                           No.&nbsp;1 to the Registrant&rsquo;s Registration Statement on Form&nbsp;S-1 (File No.&nbsp;333-217309)
                                           under the Securities Act filed on May 12, 2017; and</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment
                                           No.&nbsp;2 to the Registrant&rsquo;s Registration Statement on Form&nbsp;S-1 (File No.&nbsp;333-215963)
                                           under the Securities Act filed on March 23, 2017; and</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                           description of the Company&rsquo;s common stock, par value $0.0001 per share, contained
                                           in the Registrant&rsquo;s Form&nbsp;8-A filed under the Exchange Act on April 14, 2017
                                           and any amendment or report filed for the purpose of updating such description.</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
  documents that we file with the Commission pursuant to Sections 13(a), 13(c), 14, and 15(d)&nbsp;of the Exchange Act (other than
  any report or portion thereof furnished or deemed furnished under any Current Report on Form&nbsp;8-K) subsequent to the date
  of this registration statement and prior to the filing of a post-effective amendment to this registration statement that indicates
  that all securities offered under this reoffer prospectus have been sold, or that deregisters all securities then remaining unsold,
  will be deemed to be incorporated in this registration statement by reference and to be a part hereof from the date of filing
  of such documents.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
  statement contained in a document we incorporate by reference will be modified or superseded for all purposes to the extent that
  a statement contained in this reoffer prospectus (or in any other document that is subsequently filed with the Commission and
  incorporated by reference) modifies or is contrary to that previous statement. Any statement so modified or superseded will not
  be deemed part of this reoffer prospectus except as so modified or superseded.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  will provide without charge to each person to whom a copy of this reoffer prospectus is delivered, upon the written or oral request
  of any such person, a copy of any document described above (other than exhibits). Requests for such copies should be directed
  to HealthLynked Corp., 1726 Medical Blvd., Suite 101, Naples, Florida 34110, Attention: CFO, telephone number: (<FONT STYLE="background-color: white">239)
  513-1992</FONT>.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
  should rely only on the information incorporated by reference or provided in this reoffer prospectus or any prospectus supplement.
  We have not authorized anyone else to provide you with different information. You should not assume that the information in this
  reoffer prospectus or any prospectus supplement is accurate as of any date other than the date on the front page&nbsp;of those
  documents.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a10"></A>DISCLOSURE
  OF COMMISSION POSITION ON INDEMNIFICATION</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOR
  SECURITIES ACT LIABILITIES</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Insofar
  as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling
  the registrant, the registrant has been informed that in the opinion of the Commission such indemnification is against public
  policy as expressed in the Securities Act and is therefore unenforceable.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a11"></A>WHERE&nbsp;YOU
  CAN FIND MORE INFORMATION</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, and in accordance therewith
  file annual, quarterly and current reports and other information with the Securities and Exchange Commission. Such reports and
  other information can be read and copied at the Securities and Exchange Commission&rsquo;s public reference facilities at 100
  F Street, N.E., Washington, D.C. 20549, at prescribed rates. Please call the Securities and Exchange Commission at 1-800-732-0330
  for further information on the operation of the public reference facilities. In addition, the Securities and Exchange Commission
  maintains a website that contains reports and information statements and other information regarding registrants that file electronically
  with the Securities and Exchange Commission. The address of the Securities and Exchange Commission&rsquo;s website is <U>www.sec.gov</U>.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  make available free of charge on or through our website at www.healthlynked.com, all of our filings pursuant to the Exchange Act
  and Securities Act, as soon as reasonably practicable after we electronically file such material with or otherwise furnish it
  to the Securities and Exchange Commission. Information on our website is not incorporated by reference in this prospectus and
  is not a part of this prospectus.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 30; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>HEALTHLYNKED
  CORP.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,517,496
  SHARES OF COMMON STOCK</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">REOFFER
  PROSPECTUS</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">May
  22, 2017</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  
  <!-- Field: Page; Sequence: 31 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PART
  II</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>INFORMATION
  NOT REQUIRED IN THE PROSPECTUS</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item
  3. Incorporation of Documents by Reference.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  following documents, heretofore filed by us with the Commission pursuant to the Securities Act or the Exchange Act, are hereby
  incorporated by reference, except as superseded or modified herein:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Quarterly
                                           Report on Form 10-Q filed on May 15, 2017</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
                                           Reports on Form&nbsp;8-K (excluding any reports or portions thereof that are deemed to
                                           be furnished and not filed) filed on May 16, 2017 and May 10, 2017;</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment
                                           No.&nbsp;1 to the Registrant&rsquo;s Registration Statement on Form&nbsp;S-1 (File No.&nbsp;333-217309)
                                           under the Securities Act filed on May 12, 2017; and</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment
                                           No.&nbsp;2 to the Registrant&rsquo;s Registration Statement on Form&nbsp;S-1 (File No.&nbsp;333-215963)
                                           under the Securities Act filed on March 23, 2017; and</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
  <TD STYLE="width: 54pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.25pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                           description of the Company&rsquo;s common stock, par value $0.0001 per share, contained
                                           in the Registrant&rsquo;s Form&nbsp;8-A filed under the Exchange Act on April 14, 2017
                                           and any amendment or report filed for the purpose of updating such description.&nbsp;</FONT></TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
  documents that we file with the Commission pursuant to Sections 13(a), 13(c), 14, and 15(d)&nbsp;of the Exchange Act (other than
  any report or portion thereof furnished or deemed furnished under any Current Report on Form&nbsp;8-K) subsequent to the date
  of this registration statement and prior to the filing of a post-effective amendment to this registration statement that indicates
  that all securities offered under this reoffer prospectus have been sold, or that deregisters all securities then remaining unsold,
  will be deemed to be incorporated in this registration statement by reference and to be a part hereof from the date of filing
  of such documents.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
  statement contained in a document we incorporate by reference will be modified or superseded for all purposes to the extent that
  a statement contained in this reoffer prospectus (or in any other document that is subsequently filed with the Commission and
  incorporated by reference) modifies or is contrary to that previous statement. Any statement so modified or superseded will not
  be deemed part of this reoffer prospectus except as so modified or superseded.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  will provide without charge to each person to whom a copy of this reoffer prospectus is delivered, upon the written or oral request
  of any such person, a copy of any document described above (other than exhibits). Requests for such copies should be directed
  to HealthLynked Corp., 1726 Medical Blvd., Suite 101, Naples, Florida 34110, Attention: CFO, telephone number: (<FONT STYLE="background-color: white">239)
  513-1992</FONT>.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
  should rely only on the information incorporated by reference or provided in this reoffer prospectus or any prospectus supplement.
  We have not authorized anyone else to provide you with different information. You should not assume that the information in this
  reoffer prospectus or any prospectus supplement is accurate as of any date other than the date on the front page&nbsp;of those
  documents.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item
  4. &nbsp;Description of Securities.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Not
  applicable.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item
  5. &nbsp;Interests of Named Experts and Counsel.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Not
  applicable.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>
  
  <!-- Field: Page; Sequence: 32; Options: NewSection; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item
  6.&nbsp; Indemnification of Directors and Officers.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nevada
  Revised Statutes (&ldquo;NRS&rdquo;) Sections 78.7502 and 78.751 provide us with the power to indemnify any of our directors and
  officers. The director or officer must have conducted himself/herself in good faith and reasonably believe that his/her conduct
  was in, or not opposed to, our best interests. In a criminal action, the director, officer, employee or agent must not have had
  reasonable cause to believe his/her conduct was unlawful.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
  NRS Section 78.751, advances for expenses may be made by agreement if the director or officer affirms in writing that he/she believes
  he/she has met the standards and will personally repay the expenses if it is determined such officer or director did not meet
  the standards.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
  are also permitted to apply for insurance on behalf of any director, officer, employee or other agent for liability arising out
  of his actions, whether or not the NRS would permit indemnification.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Insofar
  as indemnification for liabilities arising under the Securities Act may be permitted for our directors, officers and controlling
  persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Commission such indemnification
  is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item
  7.&nbsp; Exemption from Registration Claimed.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
  restricted securities that may be reoffered or resold by the Selling Securityholders pursuant to the reoffer prospectus included
  herein were stock awards granted under the Plan and were deemed to be exempt from registration under the Securities Act, in reliance
  on Section 4(a)(2) of the Securities Act, as transactions by an issuer not involving a public offering, and/or Rule 701 under
  the Securities Act, which relates to exemptions for offers and sales of securities pursuant to certain compensatory benefit plans.&nbsp;&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item
  8.&nbsp; Exhibits.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 13%; text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
      Number</B></FONT></TD>
      <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 86%; text-align: center; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
      </FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><A HREF="fs82017ex4i_healthlynked.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016 Equity Incentive Plan* </FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif; background-color: White">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><A HREF="fs82017ex5i_healthlynked.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Sichenzia Ross Ference Kesner LLP</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="fs82017ex23i_healthlynked.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of RBSM LLP</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif; background-color: White">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="fs82017ex5i_healthlynked.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Sichenzia Ross Ference Kesner LLP (included in Exhibit 5.1)</FONT></A></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">*
  Replaces version filed as Exhibit 10.17 to the Company&rsquo;s Draft Registration Statement on Form S-1 filed with the Commission
  on January 9, 2017, which was not a final version</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item
  9. Undertakings.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A.
  The undersigned Registrant hereby undertakes:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.
  To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;To
  include any prospectus required by section 10(a)(3)&nbsp;of the Securities Act;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;To
  reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent
  post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
  forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
  the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
  end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;if,
  in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price
  set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective Registration Statement.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Page; Sequence: 33; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;To
  include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement
  or any material change to such information in the Registration Statement;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Provided,
  however,</I>&nbsp;that paragraphs (A)(1)(i)&nbsp;and (A)(1)(ii)&nbsp;do not apply if the information required to be included in
  a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant
  pursuant to section&nbsp;13 or section&nbsp;15(d)&nbsp;of the Exchange Act that are incorporated by reference in the Registration
  Statement.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.
  That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
  to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time
  shall be deemed to be the initial bona fide offering thereof.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.
  To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
  at the termination of the offering.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">B.
  The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
  of the Registrant&rsquo;s annual report pursuant to Section&nbsp;13(a)&nbsp;or Section&nbsp;15(d)&nbsp;of the Exchange Act (and,
  where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant to section 15(d)&nbsp;of the Exchange
  Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating
  to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide
  offering thereof.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">C.
  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
  persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion
  of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
  In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred
  or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding)
  is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant
  will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
  jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will
  be governed by the final adjudication of such issue.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  
  <!-- Field: Page; Sequence: 34; Value: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SIGNATURES</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
  to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe
  that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its
  behalf by the undersigned, thereunto duly authorized, in the City of Naples, State of Florida, on May 22, 2017</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HEALTHLYNKED
      CORP.</B> &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 60%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 4%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 36%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
      Michael Dent </FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
      Dent</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
      Executive Officer and Chairman<BR>
  (Principal Executive Officer) </FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
      <I></I></FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
      George O&rsquo;Leary</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
      O&rsquo;Leary</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
      Financial Officer and Director <BR>
  (Principal Accounting Officer)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
  to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
  capacities and on the dates indicated.</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="width: 25%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
      <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 53%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
      <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="width: 18%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
      Michael Dent</FONT></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief
  Executive Officer and Chairman</FONT><BR></P></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
      22, 2017</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
      Dent</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif">(Principal Executive Officer)</TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif">
      <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
      George O&rsquo;Leary</FONT></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
  Financial Officer and Director</FONT></TD>
      <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
      22, 2017</FONT></TD></TR>
  <TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
      O&rsquo;Leary</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Principal Accounting Officer)</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-4</P>
  
  
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  
  
  <P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"></P>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "fs82017_healthlynked.htm", "description": "REGISTRATION STATEMENT", "secsgml_size_bytes": 365015}]
metadata_filer: {"company-data": {"conformed-name": "HealthLynked Corp", "cik": "0001680139", "assigned-sic": "8011", "irs-number": "471634127", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-218175", "film-number": "17861937"}, "business-address": {"street1": "1726 MEDICAL BLVD", "street2": "SUITE 101", "city": "NAPLES", "state": "FL", "zip": "34110", "phone": "561 955 0727"}, "mail-address": {"street1": "1726 MEDICAL BLVD", "street2": "SUITE 101", "city": "NAPLES", "state": "FL", "zip": "34110"}}
text: As
  filed with the Securities and Exchange Commission on May 22, 2017
  Registration
  No. 333-________
  UNITED
  STATES
  SECURITIES
  AND EXCHANGE COMMISSION
  Washington,
  D.C. 20549
  FORM
  S-8
  REGISTRATION
  STATEMENT UNDER THE SECURITIES ACT OF 1933
  HealthLynked
  Corp.
  (Exact
  name of registrant as specified in its charter)
  Nevada
  47-1634127
  (State
  or other jurisdiction of
  incorporation
          or organization)
  (I.R.S.
  Employer
  Identification
          No.)
  1726
  Medical Blvd Suite 101
  Naples,
  Florida 34110
  (Address
  of principal executive offices) (Zip Code)
  2016
  Equity Incentive Plan
  (Full
  title of the plan)
  Michael
  Dent, MD
  Chief
  Executive Officer
  HealthLynked
  Corp.
  1726
  Medical Blvd Suite 101
  Naples,
  Florida 34110
  (Name
  and Address of agent for service)
  (239)
  513-1992
  (Telephone
  number, including area code, of agent for service)
  With
  a copy to:
  Gregory
  Sichenzia, Esq.
  Avital
  Perlman, Esq.
  Sichenzia
  Ross Ference Kesner LLP
  61
  Broadway, 32
  nd
  Floor
  New
  York, NY 10006
  Phone
  (212) 930-9700
  Fax
  (212) 930-9725
  Indicate
  by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
  company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"
  "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act:
  Large
      accelerated filer ☐
  Accelerated
      filer   ☐
  Non-accelerated
      filer   ☐
  Smaller
      Reporting Company ☒
  Emerging
      Growth Company ☒
  If
  an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
  complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
  ☐
  CALCULATION
  OF REGISTRATION FEE
  Title of Securities to be Registered
  Amount to be
  Registered (1)
  Proposed
  Maximum Offering
  Price Per Share
  Proposed
  Maximum
  Aggregate Offering
  Price
  Amount of
  Registration Fee
  Common Stock, $0.0001 par value
  2,049,996
  (2)
  $
  0.12
  (3)
  $
  245,999.52
  $
  28.51
  Common Stock, $0.0001 par value
  1,467,500
  (4)
  $
  0.80
  (5)
  $
  1,174,000.00
  $
  136.07
  Common Stock, $0.0001 par value to be issued under the Plan
  11,986,184
  (6)
  $
  0.80
  (5)
  $
  9,588,947.20
  $
  1,111.36
  TOTAL
  15,503,680
  $
  10,470,799.36
  $
  1,275.94
  (1)
  This
      Registration Statement also registers an indeterminable number of additional securities to be offered or issued upon adjustments
      or changes made to registered securities by reason of any stock splits, stock dividends or similar transactions as permitted
      by Rule 416(a) and Rule 416(b) under the Securities Act of 1933, as amended, or the Securities Act.
  (2)
  Represents
      shares of common stock issuable pursuant to stock option awards outstanding under the 2016 Equity Incentive Plan (the "Plan").
  (3)
  Estimated
      solely for the purpose of calculating the registration fee pursuant to Rule 457(h) under the Securities Act, and based upon
      the weighted average price at which such options may be exercised.
  (4)
  Represents
      common stock awards issued under the Plan.
  (5)
  Estimated
          solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) under the Securities Act. The
          fee is calculated on the basis of the average of the high and low sale prices for the registrant's common stock
          as reported on the OTCQB on May 19, 2017.
  (6)
  Represents
      shares of common stock reserved for future issuance pursuant to the Plan.
  EXPLANATORY
  NOTE
  This
  registration statement registers 2,049,996 shares of common stock, par value $0.0001 per share, of HealthLynked Corp. ("we",
  "us", "our", the "Company" or "Registrant") underlying options previously granted
  under the HealthLynked Corp. 2016 Equity Incentive Plan (the "Plan), 1,467,500 shares of restricted stock previously granted
  under the Plan, and 11,986,184 shares of common stock reserved for issuance under the Plan.
  This
  Registration Statement also includes a prospectus (which we refer to as the reoffer prospectus) prepared in accordance with General
  Instruction C of Form S-8 and in accordance with the requirements of Part I of Form S-3. The reoffer prospectus may be used for
  reofferings and resales of certain of the shares of our common stock listed above that may be deemed to be "control securities"
  and/or "restricted securities" under the Securities Act of 1933, as amended (the "Securities Act"), and
  the rules and regulations promulgated thereunder. These are shares that were or may be acquired by our officers, directors and
  affiliates, or that were acquired by our employees or consultants, under an employee benefit plan. Such officers, directors, affiliates,
  employees and consultants are the selling stockholders identified in the reoffer prospectus. The amount of shares to be offered
  or resold by means of this reoffer prospectus by each selling stockholder, and any other person with whom he or she is acting
  in concert for the purpose of selling our securities, may not exceed, during any three-month period, the amount specified in Rule
  144(e) of the Securities Act.
  PART
  I
  INFORMATION
  REQUIRED IN THE SECTION 10(a) PROSPECTUS
  Item
      1.
  Plan
      Information.
  The
  Company will provide each recipient of a grant under the Plan (the "Recipients") with documents that contain information
  related to the Plan, and other information including, but not limited to, the disclosure required by Item 1 of Form S-8, which
  information is not required to be and are not being filed as a part of this Registration Statement on Form S-8 (the "Registration
  Statement") or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. The foregoing information
  and the documents incorporated by reference in response to Item 3 of Part II of this Registration Statement, taken together, constitute
  a prospectus that meets the requirements of Section 10(a) of the Securities Act. A Section 10(a) prospectus will be given to each
  Recipient who receives common stock covered by this Registration Statement, in accordance with Rule 428(b)(1) under the Securities
  Act.
  Item
      2.
  Registrant
      Information and Employee Plan Annual Information.
  We
  will provide to each Recipient a written statement advising of the availability of documents incorporated by reference in Item
  3 of Part II of this Registration Statement (which documents are incorporated by reference in this Section 10(a) prospectus) and
  of documents required to be delivered pursuant to Rule 428(b) under the Securities Act without charge and upon written or oral
  request by contacting:
  George
  O'Leary
  Chief
  Financial Officer
  HealthLynked
  Corp.
  1726
  Medical Blvd Suite 101
  Naples,
  Florida 34110
  REOFFER
  PROSPECTUS
  3,517,496
  Shares
  Common
  Stock
  Issued
  or issuable under certain awards
  granted
  under the Plan
  This
  reoffer prospectus relates to the public resale, from time to time, of an aggregate of 3,517,496 shares (the "Shares")
  of our common stock, $0.0001 par value per share by certain securityholders identified herein in the section entitled "Selling
  Securityholders". Such shares have been or may be acquired in connection with awards granted under the HealthLynked
  Corp. 2016 Equity Incentive Plan (the "Plan"). The amount of shares to be reoffered or resold by means of this prospectus
  by each Selling Securityholder, and any other person with whom such Selling Securityholder is acting in concert for the purpose
  of selling our securities, may not exceed, during any three-month period, the amount specified in Rule 144(e) of the
  Securities Act of 1933, as amended (the "Securities Act"). You should read this prospectus carefully before you invest
  in our common stock.
  Such
  resales shall take place on the OTCQB, or such other stock market or exchange on which our common stock may be listed or quoted,
  in negotiated transactions or otherwise, at market prices prevailing at the time of the sale or at prices otherwise negotiated
  (see "Plan of Distribution" starting on page 22 of this prospectus). We will receive no part of the proceeds from
  sales made under this reoffer prospectus. The Selling Securityholders will bear all sales commissions and similar expenses. Any
  other expenses incurred by us in connection with the registration and offering and not borne by the Selling Securityholders will
  be borne by us.
  This
  reoffer prospectus has been prepared for the purposes of registering the common shares under the Securities Act to allow for future
  sales by Selling Securityholders on a continuous or delayed basis to the public without restriction. We have not entered into
  any underwriting arrangements in connection with the sale of the shares covered by this reoffer prospectus. The Selling Securityholders
  identified in this reoffer prospectus, or their pledgees, donees, transferees or other successors-in-interest, may offer the shares
  covered by this reoffer prospectus from time to time through public or private transactions at prevailing market prices, at prices
  related to prevailing market prices or at privately negotiated prices.
  Investing
  in our common stock involves risks. See "Risk Factors" beginning on page 4 of this reoffer prospectus. These are
  speculative securities.
  Our
  common stock is quoted on the OTCQB under the symbol "HLYK" and the last reported sale price of our common stock on
  May 19, 2017 was $0.80 per share.
  NEITHER
  THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR
  DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
  The
  date of this prospectus is May 22, 2017
  HEALTHLYNKED
  CORP.
  TABLE
  OF CONTENTS
  Page
  Cautionary
      Statement Regarding Forward-Looking Statements
  1
  Prospectus
      Summary
  2
  Risk
      Factors
  4
  Use
      of Proceeds
  18
  Selling
      Securityholders
  19
  Plan
      of Distribution
  22
  Legal
      Matters
  23
  Experts
  23
  Incorporation
      of Certain Documents by Reference
  24
  Disclosure
      of Commission Position on Indemnification For Securities Act Liabilities
  24
  Where
      You can Find Additional Information
  24
  Table of Contents
  Except
  where the context otherwise requires, the terms, "we," "us," "our" or "the Company,"
  refer to the business of HealthLynked Corp., a Nevada corporation, and its wholly-owned subsidiary Naples Women's Center
  LLC ("NWC").
  CAUTIONARY
  STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
  This
  prospectus contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs
  or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development
  plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking
  statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such
  statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks
  described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date
  hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking
  statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based
  on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal
  surveys, independent industry publications and other publicly available information.
  1
  Table of Contents
  PROSPECTUS
  SUMMARY
  The
  Securities and Exchange Commission (the "Commission") allows us to ''incorporate by reference''
  certain information that we file with the Commission, which means that we can disclose important information to you by referring
  you to those documents. The information incorporated by reference is considered to be part of this prospectus, and information
  that we file later with the Commission will update automatically, supplement and/or supersede the information disclosed in this
  prospectus. Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus shall
  be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus
  or in any other document that also is or is deemed to be incorporated by reference in this prospectus modifies or supersedes such
  statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute
  a part of this prospectus. You should read the following summary together with the more detailed information regarding our company,
  our common stock and our financial statements and notes to those statements appearing elsewhere in this prospectus or incorporated
  herein by reference.
  Overview
  HealthLynked
  is a Nevada corporation formed in August 2014. We are the provider of a cloud-based service, the HealthLynked Network, which is
  a fully integrated web site that that enables patients and their providers to record, archive and access patients' medical
  information, book real time and future appointments via the internet and physician encounters via telemedicine. We currently anticipate
  launching the network in the first half of 2017 under the domain name "www.HealthLynked.com".
  At
  www.HealthLynked.com
  , patients will be able to complete a detailed personal medical history, including current medications,
  past surgical history, allergies and family medical history. Patients and their treating physicians will also be able to update
  the information as needed to provide an up to date and complete medical record. The HealthLynked Network will be accessible 24
  hours a day, seven days a week on web browsers and on a mobile phone application. We believe that the HealthLynked Network will
  provide numerous benefits for patients, medical providers, hospitals, emergency rooms and schools. Further, we believe that wait
  times in physicians' offices will be shortened by avoiding the need for repetitive paperwork thereby reducing intake times and
  allowing physicians to see more patients and have more accurate patient information.
  2
  Table of Contents
  Patient
  data will be stored in conformity with the
  Health Insurance Portability and Accountability Act
  of 1996, or "HIPAA".
  The network will utilize Amazon AWS infrastructure which will use Amazon "HIPPA" Complaint Servers along with Amazon
  RDS with LAMP, HTML5 and several JavaScript framework, including Angular and React. Recommendations for end users are 512 kbps+
  internet connection speed and a web browser such as Google Chrome, Internet Explorer, Mozilla Firefox, Safari or handheld devices
  such as iOS devices, android phones or tablets. Our developers may utilize third party controls for functionality or user interface
  where the use of those controls adds value to the system beyond custom creation of new tools. We intend to adjust forward compatibility
  for major browser version updates, new browsers, operating system updates or new operating system as needed. The HealthLynked
  Network will be electronic medical record ("EMR") agnostic and will be compatible with all electronic medical records
  systems, allowing for minimal barriers to participation and broader penetration of the market.
  In
  September 2014, we acquired the Naples Women's Center ("NWC") an OB/GYN practice in Naples, Florida that was formed
  in 1996 by Dr. Michael Dent, our Chief Executive Officer and Chairman. At the time of the acquisition, NWC was a related party.
  Through NWC, we offer various services including Obstetrical services for high and low risk patients, in office ultrasonography,
  and prenatal testing. We also provide gynecological services that include general physical exams, surgical procedures such as
  hysterectomy, bladder incontinence procedures, pelvic reconstruction, sterilization, endometrial ablation, advanced robotic surgery,
  contraceptive management and infertility testing and treatment. We believe that this acquisition provides a foundation for ongoing
  development of the HealthLynked Network by allowing us to register NWC's approximately 6,000 active patients and to utilize
  the expertise of our employed physicians to help in the design and strategy for deployment of the HealthLynked Network. It is
  anticipated that in the future, we may acquire other medical practices as we see fit to further develop, test and deploy the HealthLynked
  Network into new strategic regional areas throughout the country.
  Corporate
  Information
  We
  were incorporated on August 6, 2014 under the laws of the State of Nevada. On October 11, 2011, we changed our name to HealthLynked
  Corp. In August 2014, we acquired the NWC, an OB/GYN practice in Naples, Florida that was established in 1996. Our principal executive
  offices are located at
  1726 Medical Blvd Suite 101, Naples, Florida 34110
  and our
  telephone number is (
  239) 513-1992
  .
  The
  Offering
  Outstanding
      Common Stock:
  69,703,640
      shares of our common stock are outstanding as of May 19, 2017.
  Common
      Stock Offered:
  Up
      to 3,517,496 shares of common stock for sale by the Selling Securityholders (which include our executive officers and directors)
      for their own account pursuant to the Plan.
  Selling
      Securityholders:
  The
      Selling Securityholders are set forth in the section entitled "Selling Securityholders" of this reoffer prospectus
      on page 19.
  Use
      of proceeds:
  We
      will not receive any proceeds from the sale of our common stock by the Selling Securityholders. We would, however, receive
      proceeds upon the exercise of the stock options by those who receive options under the Plans and exercise such options for
      cash. Any cash proceeds will be used by us for general corporate purposes.
  Risk
      Factors:
  The
      securities offered hereby involve a high degree of risk. See "Risk Factors."
  OTCQB
      trading symbol:
  HLYK
  3
  Table of Contents
  RISK
  FACTORS
  You
  should carefully consider the risks described below before making an investment decision. The risks described below are not the
  only ones we face. Additional risks we are not presently aware of or that we currently believe are immaterial may also impair
  our business operations. Our business could be harmed by any of these risks. The trading price of our common stock could decline
  due to any of these risks, and you may lose all or part of your investment. In assessing these risks, you should also refer to
  the other information contained or incorporated by reference into this prospectus, including our financial statements and related
  notes.
  FINANCIAL
  AND GENERAL BUSINESS RISKS
  Our
  subsidiary the Naples Women's Center, currently our only source of income, has achieved profitability and incurred losses
  in the past and may not be able to achieve profitability in the future.
  Even
  though our subsidiary the Naples Women's Center ("NWC") was established in 1996, it is subject to many of the
  risks inherent in the practice of medicine. We cannot give any assurance that NWC's operations will continue as currently
  intended and no assurance can be given that we can continue to receive reimbursement from third party payers. Further, changes
  in Healthcare regulations in the coming years may negatively impact our operations. NWC realized segment income from operations
  for the year ended December 31, 2015, but incurred segment losses in the years ended December 31, 2014 and 2016 as well as in
  the three months ended March 31, 2017 and 2016. We expect to hire approximately five additional new physicians over the next two
  to five years, which will result in increased costs and expenses, which may result in future operating losses.
  We
  may never be able to implement our proposed online personal medical information and archiving system and as such, an investment
  in us at this stage of our business is extremely risky.
  The
  HealthLynked Network is in the developmental stages and we currently anticipate launching the network sometime during the first
  six months of 2017. However, we cannot guarantee how long it will take us to develop our technology. In addition, we cannot predict
  whether physicians and patients will adopt our technology, or even if they do, the timing of such adoption. Further, it is possible
  that other competitors will greater resources could enter the market and make it more difficult for us to attract or keep customers.
  Consequently, at this phase of our development, our future is speculative and depends on the proper execution of our business
  model.
  No
  assurance can be given that we will be able to timely repay the amounts due on our convertible notes.
  In
  July 2016, we issued a 6% fixed convertible secured promissory note due July 11, 2017 in the principal amount of $550,000 (the
  "Secured Note"). At any time and from time to time, the holder of the note may convert, in whole or in part, the outstanding
  and unpaid principal amount under the Secured Note into shares of the Company's common stock at a conversion price of $0.08
  per share. In addition, we also issued a 10% fixed convertible commitment fee promissory note due July 11, 2017 in the principal
  amount of $50,000 (the "Fee Note" and collectively with the Secured Note, the "Convertible Notes"). At
  the present time, no assurance can be given that we will earn sufficient revenues or secure the necessary financing, if needed,
  to timely pay the amounts owed under the Convertible Notes. The Secured Note is secured by substantially all of our assets, including,
  but not limited to, receivables of NWC, machinery, equipment, contracts rights, and letters of credits. If we fail to timely repay
  the amounts owed under the Secured Note, a default may allow the lender under the relevant instruments to accelerate the related
  debt and to exercise their remedies under these agreements, which will typically include the right to declare the principal amount
  of that debt, together with accrued and unpaid interest and other related amounts, immediately due and payable, to exercise any
  remedies the lender may have to foreclose on assets that are subject to liens securing that debt. As of March 31, 2017, $574,140
  in principal and interest was outstanding under the Secured Note and $52,425 in principal and interest was outstanding under the
  Fee Note. We expect to repay the Convertible Notes from outside funding sources, including but not limited to amounts available
  upon the exercise of the Put Right granted to us under an investment agreement entered into in July 2016 (the "Investment
  Agreement") with Iconic Holdings LLC ("Iconic"), sales of our equity, loans from related parties and others,
  or to satisfy the Convertible Notes through the issuance of shares upon conversion pursuant to the terms of the Convertible Notes.
  No assurances can be given that we will be able to access sufficient outside capital in a timely fashion in order to repay the
  Convertible Notes before they mature. In order to access cash available under the Investment Agreement or satisfy the Convertible
  Notes through the issuance of shares upon conversion, our common stock must be listed on a recognized stock exchange or market
  and the shares underlying the arrangement must be subject to an effective registration statement. If we are unable to meet these
  requirements, we will not have access to funds under this arrangement.
  4
  Table of Contents
  We
  have substantial future capital needs and our ability to continue as a going concern depends upon our ability to raise additional
  capital and achieve profitable operations.
  We
  currently anticipate that our available cash resources will be sufficient to meet our presently anticipated working capital requirements
  through the second quarter of 2017. However, we anticipate that we will need an additional $250,000 in the third and fourth quarters
  of 2017 to properly execute our business plan. We may also need to raise additional funds in order to support more rapid expansion,
  develop new or enhanced services and products, hire employees, respond to competitive pressures, acquire technologies or respond
  to unanticipated requirements. Management's plans include attempting to improve our profitability and our ability to generate
  sufficient cash flow from operations to meet our operating needs on a timely basis, obtaining additional working capital funds
  through equity and debt financing arrangements, and restructuring on-going operations to eliminate inefficiencies to increase
  our cash balances. However, there can be no assurance that these plans and arrangements will be sufficient to fund our ongoing
  capital expenditures, working capital, and other requirements. Management intends to make every effort to identify and develop
  sources of funds. The outcome of these matters cannot be predicted at this time. There can be no assurance that any additional
  financings will be available to the Company on satisfactory terms and conditions, if at all. If adequate funds are not available
  on acceptable terms, we may be unable to develop or enhance our services and products, take advantage of future opportunities
  or respond to competitive pressures or unanticipated requirements, which could have a material adverse effect on our business,
  financial condition and operating results. Further, we may seek to raise additional funds through the issuance of equity securities,
  in which case, the percentage ownership of our shareholders will be reduced and holders may experience additional dilution in
  net book value per share.
  Our
  future success depends on our ability to execute our business plan by fully developing our online medical records platform and
  recruiting physicians and patients to adopt and use the system. However, there is no guarantee that we will be able to successfully
  implement our business plan.
  Our
  operations to date have been limited to the medical services provided by the NWC. The online medical records platform we seek
  to provide through the HealthLynked Network is in the early stages of development and as such, we have not yet demonstrated our
  ability to successfully develop or market this platform. As of the date of this prospectus, we have not entered into any agreements
  with third party doctors or patients to use our system for their medical records and there is no assurance that we will be able
  to enter into such agreements in the future.
  We
  may not be able to effectively control and manage our growth.
  Our
  strategy envisions a period of potentially rapid growth in our physician network over the next five years based on aggressively
  increasing our marketing efforts. We intend to rely on the efforts of our newly engaged Chief Commercial Officer to attempt to
  enroll over 2,000 new physicians by December 2017 with that level of growth doubling every year over the next five years. We currently
  maintain a small in house programming, IT, administrative and sales personnel. The capacity to service the online medical records
  platform and our expected growth may impose a significant burden on our future planned administrative and operational resources.
  The growth of our business may require significant investments of capital and increased demands on our management, workforce and
  facilities. We will be required to substantially expand our administrative and operational resources and attract, train, manage
  and retain qualified employees, management and other personnel. Failure to do so, or to satisfy such increased demands would interrupt
  or have a material adverse effect on our business and results of operations.
  5
  Table of Contents
  The
  departure or loss of Dr. Michael Dent could disrupt our business.
  We
  depend heavily on the continued efforts of Dr. Michael Dent, Chief Executive Officer and Chairman of the Board. Dr. Dent is essential
  to our strategic vision and day-to-day operations and would be difficult to replace. While we have entered into a four-year written
  employment contract with Dr. Dent effective July 1, 2016, we cannot be certain that Dr. Dent will continue with us for any particular
  period of time. The departure or loss of Dr. Dent, or the inability to hire and retain a qualified replacement, could negatively
  impact our ability to manage our business.
  The
  departure or loss of Robert Horel, our Chief Commercial Officer, could disrupt our business.
  We
  depend heavily on the continued efforts of Robert Horel, our Chief Commercial Officer. Mr. Horel's expertise and contacts
  are essential to our sales strategy and would be difficult to replace. While we have entered into a written employment contract
  with Mr. Horel effective November 28, 2016, we cannot be certain that Mr. Horel will continue with us for any particular period
  of time. The departure or loss of Mr. Horel, or the inability to hire and retain a qualified replacement, could negatively impact
  our ability to manage our business.
  George
  O'Leary
  may devote only a portion of his business time to us, which could materially
  and adversely affect us and our business
  .
  Mr.
  O'Leary, our Chief Financial Officer, has entered into a two-year consultancy agreement with us effective July 1, 2016.
  However, under the terms of such agreement, he is not required to work exclusively for us and does not devote all of his time
  to our operations. Presently, Mr. O'Leary allocates only a portion of his time to the operation of our business. As Mr.
  O'Leary is currently providing consulting services elsewhere in addition to serving as our Chief Financial Officer, he is
  able to commit to us only up to twenty-five hours a week but is not obligated to devote any particular amount of time to our business
  or affairs.
  The
  healthcare industry is highly regulated, and government authorities may determine that we have failed to comply with applicable
  laws, rules or regulations.
  The
  healthcare industry, healthcare information technology, the online medical records platform services that we provide and the physicians'
  medical practices we engage in through NWC are subject to extensive and complex federal, state and local laws, rules and regulations,
  compliance with which imposes substantial costs on us. Of particular importance are the provisions summarized as follows:
  ●
  federal
      laws (including the federal False Claims Act) that prohibit entities and individuals from knowingly or recklessly making claims
      to Medicaid, Medicare and other government-funded programs that contain false or fraudulent information or from improperly
      retaining known overpayments;
  ●
  a
      provision of the Social Security Act, commonly referred to as the "anti-kickback" statute, that prohibits the
      knowing and willful offer, payment, solicitation or receipt of any bribe, kickback, rebate or other remuneration, in cash
      or in kind, in return for the referral or recommendation of patients for items and services covered, in whole or in part,
      by federal healthcare programs, such as Medicaid and Medicare;
  ●
  a
      provision of the Social Security Act, commonly referred to as the Stark Law, that, subject to limited exceptions, applies
      when physicians refer Medicare patients to an entity for the provision of certain "designated health services"
      if the physician or a member of such physician's immediate family has a direct or indirect financial relationship (including
      a compensation arrangement) with the entity;
  ●
  similar
      state law provisions pertaining to anti-kickback, fee splitting, self-referral and false claims issues, which typically are
      not limited to relationships involving government-funded programs;
  ●
  provisions
      of the
  federal Health Insurance Portability and Accountability Act of 1996, as amended
      ("HIPAA")
  that prohibit knowingly and willfully executing a scheme or artifice to defraud a healthcare
      benefit program or falsifying, concealing or covering up a material fact or making any material false, fictitious or fraudulent
      statement in connection with the delivery of or payment for healthcare benefits, items or services;
  ●
  state
      laws that prohibit general business corporations from practicing medicine, controlling physicians' medical decisions
      or engaging in certain practices, such as splitting fees with physicians;
  6
  Table of Contents
  ●
  federal
      and state healthcare programs may deny our application to become a participating provider that could in turn cause us to not
      be able to treat those patients or prohibit us from billing for the treatment services provided to such patients;
  ●
  federal
      and state laws that prohibit providers from billing and receiving payment from Medicaid or Medicare for services unless the
      services are medically necessary, adequately and accurately documented and billed using codes that accurately reflect the
      type and level of services rendered;
  ●
  federal
      and state laws pertaining to the provision of services by non-physician practitioners, such as advanced nurse practitioners,
      physician assistants and other clinical professionals, physician supervision of such services and reimbursement requirements
      that may be dependent on the manner in which the services are provided and documented; and
  ●
  federal
      laws that impose civil administrative sanctions for, among other violations, inappropriate billing of services to federally
      funded healthcare programs, inappropriately reducing hospital care lengths of stay for such patients, or employing individuals
      who are excluded from participation in federally funded healthcare programs.
  In
  addition, we believe that our business, including the business conducted through NWC, will continue to be subject to increasing
  regulation, the scope and effect of which we cannot predict.
  We
  may in the future become the subject of regulatory or other investigations or proceedings, and our interpretations of applicable
  laws, rules and regulations may be challenged. For example, regulatory authorities or other parties may assert that our arrangements
  with the physicians using the HealthLynked Network constitute fee splitting and seek to invalidate these arrangements, which could
  have a material adverse effect on our business, financial condition, results of operations, cash flows and the trading price of
  our common stock. Regulatory authorities or other parties also could assert that our relationships violate the anti-kickback,
  fee splitting or self-referral laws and regulations. Such investigations, proceedings and challenges could result in substantial
  defense costs to us and a diversion of management's time and attention. In addition, violations of these laws are punishable
  by monetary fines, civil and criminal penalties, exclusion from participation in government-sponsored healthcare programs, and
  forfeiture of amounts collected in violation of such laws and regulations, any of which could have a material adverse effect on
  our overall business, financial condition, results of operations, cash flows and the trading price of our common stock.
  Federal
  and state laws that protect the privacy and security of protected health information may increase our costs and limit our ability
  to collect and use that information and subject us to penalties if we are unable to fully comply with such laws.
  Numerous
  federal and state laws and regulations govern the collection, dissemination, use, security and confidentiality of individually
  identifiable health information. These laws include:
  ●
  Provisions
      of HIPAA that limit how healthcare providers may use and disclose individually identifiable health information, provide certain
      rights to individuals with respect to that information and impose certain security requirements;
  ●
  The
      Health Information Technology for Economic and Clinical Health Act ("HITECH"), which strengthens and expands the
      HIPAA Privacy Standards and Security Standards and imposes data breach notification obligations;
  ●
  Other
      federal and state laws restricting the use and protecting the privacy and security of protected health information, many of
      which are not preempted by HIPAA;
  ●
  Federal
      and state consumer protection laws; and
  ●
  Federal
      and state laws regulating the conduct of research with human subjects.
  7
  Table of Contents
  Through
  the HealthLynked Network, we collect and maintain protected health information in paper and electronic format. New protected health
  information standards, whether implemented pursuant to HIPAA, HITECH, congressional action or otherwise, could have a significant
  effect on the manner in which we handle healthcare-related data and communicate with third parties, and compliance with these
  standards could impose significant costs on us, or limit our ability to offer certain services, thereby negatively impacting the
  business opportunities available to us.
  In
  addition, if we do not comply with existing or new laws and regulations related to protected health information, we could be subject
  to remedies that include monetary fines, civil or administrative penalties, civil damage awards or criminal sanctions.
  RISKS
  RELATED TO THE HEALTHLYNKED NETWORK
  The
  market for Internet-based personal medical information and record archiving systems may not develop substantially further or develop
  more slowly than we expect, harming the growth of our business.
  It
  is uncertain whether personal medical information and record archiving systems will achieve and sustain the high levels of demand
  and market acceptance we anticipate. Further, even though we expect NWC patients and physicians to use the HealthLynked Network,
  our success will depend, to a substantial extent, on the willingness of unaffiliated patients, physicians and hospitals to use
  our services. Some patients, physicians and hospitals may be reluctant or unwilling to use our services, because they may have
  concerns regarding the risks associated with the security and reliability, among other things, of the technology model associated
  with these services. If our target users do not believe our systems are secure and reliable, then the market for these services
  may not expand as much or develop as quickly as we expect, either of which would significantly adversely affect our business,
  financial condition, or operating results.
  If
  we do not continue to innovate and provide services that are useful to our target users, we may not remain competitive, and our
  revenues and operating results could suffer.
  Our
  success depends on our ability to keep pace with technological developments, satisfy increasingly sophisticated client requirements,
  and obtain market acceptance. Our competitors are constantly developing products and services that may become more efficient or
  appealing to our clients and users. As a result, we will be required to invest significant resources in research and development
  in order to enhance our existing services and introduce new high-quality services that clients and users will want, while offering
  these services at competitive prices.
  If
  we are unable to predict user preferences or industry changes, or if we are unable to modify our services on a timely or cost-effective
  basis, we may lose clients and target users. Our operating results would also suffer if our innovations are not responsive to
  the needs of our clients and users, are not appropriately timed with market opportunity, or are not effectively brought to market.
  As technology continues to develop, our competitors may be able to offer results that are, or that are perceived to be, substantially
  similar to or better than those generated by our services. This may force us to compete on additional service attributes and to
  expend significant resources in order to remain competitive.
  Failure
  to manage our rapid growth effectively could increase our expenses, decrease our revenue, and prevent us from implementing our
  business strategy.
  To
  manage our anticipated future growth effectively, we will need to enhance our information technology infrastructure and financial
  and accounting systems and controls, as well as manage expanded operations in geographically distributed locations. We also must
  engage and retain a significant number of qualified professional services personnel, software engineers, technical personnel,
  and management personnel. Failure to manage our rapid growth effectively could lead us to over-invest or under-invest in technology
  and operations; result in weaknesses in our infrastructure, systems, or controls; give rise to operational mistakes, losses, or
  loss of productivity or business opportunities; reduce client or user satisfaction; limit our ability to respond to competitive
  pressures; and could also result in loss of employees and reduced productivity of remaining employees. Our growth could require
  significant capital expenditures and may divert financial resources and management attention from other projects, such as the
  development of new or enhanced services. If our management is unable to effectively manage our growth, our expenses may increase
  more than expected, our revenue could decline or may grow more slowly than expected, and we may be unable to implement our business
  strategy
  8
  Table of Contents
  We
  may be unable to adequately protect, and we may incur significant costs in enforcing, our intellectual property and other proprietary
  rights.
  Our
  success depends in part on our ability to enforce our intellectual property and other proprietary rights. We expect to rely upon
  a combination of copyright, trademark, trade secret, and unfair competition laws, as well as license and access agreements and
  other contractual provisions, to protect these rights.
  Our
  attempts to protect our intellectual property through copyright, patent, and trademark registration may be challenged by others
  or invalidated through administrative process or litigation. While we intend to submit patent applications covering our integrated
  technology during 2017, the scope of issued patents, if any, may be insufficient to prevent competitors from providing products
  and services similar to ours, our patents may be successfully challenged, and we may not be able to obtain additional meaningful
  patent protection in the future. There can be no assurance that our patent registration efforts will be successful.
  Our
  expected agreements with clients, users, vendors and strategic partners will limit their use of, and allow us to retain our rights
  in, our intellectual property and proprietary information. Further, we anticipate that these agreements will grant us ownership
  of intellectual property created in the performance of those agreements to the extent that it relates to the provision of our
  services. In addition, we require certain of our employees and consultants to enter into confidentiality, non-competition, and
  assignment of inventions agreements. We also require certain of our vendors and strategic partners to agree to contract provisions
  regarding confidentiality and non-competition. However, no assurance can be given that these agreements will not be breached,
  and we may not have adequate remedies for any such breach. Further, no assurance can be given that these agreements will be effective
  in preventing the unauthorized access to, or use of, our proprietary information or the reverse engineering of our technology.
  Agreement terms that address non-competition are difficult to enforce in many jurisdictions and may not be enforceable in any
  particular case. In any event, these agreements do not prevent our competitors from independently developing technology or authoring
  clinical information that is substantially equivalent or superior to our technology or the information we distribute.
  To
  the extent that our intellectual property and other proprietary rights are not adequately protected, third parties might gain
  access to our proprietary information, develop and market products or services similar to ours, or use trademarks similar to ours,
  each of which could materially harm our business. Existing U.S. federal and state intellectual property laws offer only limited
  protection. In addition, if we resort to legal proceedings to enforce our intellectual property rights or to determine the validity
  and scope of the intellectual property or other proprietary rights of others, the proceedings could be burdensome and expensive,
  even if we were to prevail. Any litigation that may be necessary in the future could result in substantial costs and diversion
  of resources and could have a material adverse effect on our business, operating results, or financial condition.
  In
  addition, our platforms incorporate "open source" software components that are licensed to us under various public
  domain licenses. While we believe that we have complied with our obligations under the various applicable licenses for open source
  software that we use, open source license terms are often ambiguous, and there is little or no legal precedent governing the interpretation
  of many of the terms of certain of these licenses. Therefore, the potential impact of such terms on our business is somewhat unknown.
  For example, some open source licenses require that those using the associated code disclose modifications made to that code and
  such modifications be licensed to third parties at no cost. We monitor our use of open source software in an effort to avoid uses
  in a manner that would require us to disclose or grant licenses under our proprietary source code. However, there can be no assurance
  that such efforts will be successful, and such use could inadvertently occur.
  9
  Table of Contents
  We
  may be sued by third parties for alleged infringement of their proprietary rights.
  The
  software and Internet industries are characterized by the existence of a large number of patents, trademarks, and copyrights and
  by frequent litigation based on allegations of infringement or other violations of intellectual property rights. We may receive
  in the future communications from third parties claiming that we, our technology, or components thereof, infringe on the intellectual
  property rights of others. We may not be able to withstand such third-party claims against our technology, and we could lose the
  right to use third-party technologies that are the subject of such claims. Any intellectual property claims, whether with or without
  merit, could be time-consuming and expensive to resolve, divert management attention from executing our business plan, and require
  us to pay monetary damages or enter into royalty or licensing agreements. Although we intend that many of our third-party service
  providers will be obligated to indemnify us if their products infringe the rights of others, such indemnification may not be effective
  or adequate to protect us or the indemnifying party may be unable to uphold its contractual obligations.
  Moreover,
  any settlement or adverse judgment resulting from such a claim could require us to pay substantial amounts of money or obtain
  a license to continue to use the technology or information that is the subject of the claim, or otherwise restrict or prohibit
  our use of the technology or information. There can be no assurance that we would be able to obtain a license on commercially
  reasonable terms, if at all, from third parties asserting an infringement claim; that we would be able to develop alternative
  technology on a timely basis, if at all; that we would be able to obtain a license to use a suitable alternative technology or
  information to permit us to continue offering, and our clients to continue using, our affected services; or that we would not
  need to change our product and design plans, which could require us to redesign affected products or services or delay new offerings.
  Accordingly, an adverse determination could prevent us from implementing our strategy or offering our services and products, as
  currently contemplated.
  We
  may not be able to properly safeguard the information on the HealthLynked Network.
  Information
  security risks have generally increased in recent years because of new technologies and the increased activities of perpetrators
  of cyber-attacks resulting in the theft of protected health, business or financial information. A failure in, or a breach of our
  information systems as a result of cyber attacks could disrupt our business, result in the release or misuse of confidential or
  proprietary information, damage our reputation, and increase our administrative expenses. Although we plan to have robust information
  security procedures and other safeguards in place, as cyber threats continue to evolve, we may be required to expend additional
  resources to continue to enhance our information security measures or to investigate and remediate any information security vulnerabilities.
  Any of these disruptions or breaches of security could have a material adverse effect on our business, financial condition and
  results of operations.
  Our
  employees may not take all appropriate measures to secure and protect confidential information in their possession.
  Each
  of our employees is advised that they are responsible for the security of the information in our systems and to ensure that private
  information is kept confidential. Should an employee not follow appropriate security measures, including those that have been
  put in place to prevent cyber threats or attacks, the improper release of protected health information could result. The release
  of such information could have a material adverse effect our reputation and our business, financial condition, results of operations
  and cash flows.
  10
  Table of Contents
  RISKS
  RELATED TO THE PROVISION OF MEDICAL SERVICES BY NWC
  Continuing
  unfavorable economic conditions could have an adverse effect on our business.
  Although
  economic conditions in the United States have gradually improved, the number of unemployed and under-employed workers remains
  significant and economic growth has been slow. The percentage of our patient services provided through NWC that are being reimbursed
  under government-sponsored healthcare programs could increase if economic conditions do not improve or if they deteriorate and
  possibly lower patient volumes. These conditions could also lead to additional increases in the number of unemployed and under-employed
  workers and a decline in the number of private employers that offer healthcare insurance coverage to their employees. Employers
  that do offer healthcare coverage may increase the required contributions from employees to pay for their coverage and increase
  patient responsibility amounts. As a consequence, the number of patients who participate in government-sponsored programs or are
  uninsured could increase. In addition, due to the rising costs of managed care premiums and patient responsibility amounts, coupled
  with the current economic environment, NWC may experience increased bad debt due to patients' inability to pay for certain
  services. Further, it is too early to determine whether the Affordable Care Act will increase or decrease the number of our patients
  with private healthcare insurance, obtained either through employers or the recently established insurance exchanges. Payments
  received from government-sponsored programs are substantially less than payments received from private healthcare insurance programs
  (managed care and other third-party payors). In addition, payments under the recently established health care exchanges may be
  less than payments from private healthcare insurance programs. A payor mix shift from private healthcare insurance programs to
  government payors may result in an increase in NWC's estimated provision for contractual adjustments and uncollectible amounts
  and a corresponding decrease in our net patient service revenue. Further increases in the government component of our payor mix
  at the expense of other third-party payors could result in a significant reduction in our average reimbursement rates.
  Any
  state budgetary constraints could have an adverse effect on our reimbursement from Medicaid programs
  .
  As
  a result of slow economic growth and volatile economic conditions, many states are continuing to collect less revenue than they
  did in prior years and as a consequence are facing budget shortfalls and underfunded pension and other obligations. Although the
  shortfalls for the more recent budgetary years have declined, they are still significant by historical standards. The financial
  condition in Florida or other states in which we may in the future could lead to reduced or delayed funding for Medicaid programs
  and, in turn, reduced or delayed reimbursement for physician services, which could adversely affect our results of operations,
  cash flows and financial condition.
  The
  Affordable Care Act may have a significant effect on our business.
  The
  Affordable Care Act contains a number of provisions that could affect us over the next several years. These provisions include
  the establishment of health insurance exchanges to facilitate the purchase of qualified health plans, expanding Medicaid eligibility,
  subsidizing insurance premiums and creating requirements and incentives for businesses to provide healthcare benefits. Other provisions
  contain changes to healthcare fraud and abuse laws and expand the scope of the FCA.
  The
  Affordable Care Act contains numerous other measures that could affect us. For example, payment modifiers are being developed
  that will differentiate payments to physicians under federal healthcare programs based on quality and cost of care. In addition,
  other provisions authorize voluntary demonstration projects relating to the bundling of payments for episodes of hospital care
  and the sharing of cost savings achieved under the Medicare program.
  The
  Centers for Medicare and Medicaid Services ("CMS") issued a final rule under the Affordable Care Act that is intended
  to allow physicians, hospitals and other health care providers to coordinate care for Medicare beneficiaries through Accountable
  Care Organizations ("ACOs"). ACOs are entities consisting of healthcare providers and suppliers organized to deliver
  services to Medicare beneficiaries and eligible to receive a share of any cost savings the entity can achieve by delivering services
  to those beneficiaries at a cost below a set baseline and based upon established quality of care standards. We will continue to
  evaluate the impact of the ACO regulations on our business and operations.
  Many
  of the Affordable Care Act's most significant reforms, such as the establishment of state-based and federally facilitated
  insurance exchanges that provide a marketplace for eligible individuals and small employers to purchase health care insurance,
  became effective relatively recently. On October 1, 2013, individuals began enrolling in health care insurance plans offered under
  these state-based and federally-facilitated insurance exchanges, notwithstanding significant technical issues in accessing and
  enrolling in the federal online exchange. Such issues may have delayed or reduced the purchase of health care insurance by uninsured
  persons. In order to be covered on the effective date of January 1, 2014 individuals were required to enroll and pay their first
  premium by December 24, 2013, however, extensions have been, and may continue to be granted on a case by case basis depending
  on specific circumstances. Uninsured persons who do not enroll in health care insurance plans by March 31, 2014 will be required
  to pay a penalty to the Internal Revenue Service, unless a hardship exception applies. The patient responsibility costs related
  to health care plans obtained through the insurance exchanges may be high, and we may experience increased bad debt due to NWC's
  patients' inability to pay for certain services.
  11
  Table of Contents
  The
  Affordable Care Act also allows states to expand their Medicaid programs through an increase in the Medicaid eligibility income
  limit from a state's current eligibility levels to 133% of the federal poverty level. It remains unclear to what extent
  states will expand their Medicaid programs by raising the income limit to 133% of the federal poverty level. As a result of these
  and other uncertainties, we cannot predict whether there will be more uninsured patients in 2014 than anticipated when the Affordable
  Care Act was enacted.
  The
  Affordable Care Act also remains subject to continuing legislative scrutiny, including efforts by Congress to amend or repeal
  a number of its provisions as well as administrative actions delaying the effectiveness of key provisions. As a result, we cannot
  predict with any assurance the ultimate effect of the Affordable Care Act on our Company, nor can we provide any assurance that
  its provisions will not have a material adverse effect on our business, financial condition, results of operations or cash flows.
  Government-funded
  programs or private insurers may limit, reduce or make retroactive adjustments to reimbursement amounts or rates.
  A
  portion of the net patient service revenue derived from services rendered through NWC is from payments made by Medicare and Medicaid
  and other government-sponsored or funded healthcare programs (the "GHC Programs")
  .
  These government-funded programs, as well as private insurers, have taken and may continue to take steps, including a movement
  toward increased use of managed care organizations, value-based purchasing, and new patient care models to control the cost, eligibility
  for, use and delivery of healthcare services as a result of budgetary constraints and cost containment pressures due to unfavorable
  economic conditions, rising healthcare costs and for other reasons. These government-funded programs and private insurers may
  attempt other measures to control costs, including bundling of services and denial of, or reduction in, reimbursement for certain
  services and treatments. As a result, payments from government programs or private payors may decrease significantly. Also, any
  adjustment in Medicare reimbursement rates may have a detrimental impact on our reimbursement rates not only for Medicare patients,
  but also because Medicaid and other third-party payors often base their reimbursement rates on a percentage of Medicare rates.
  Our business may also be materially affected by limitations on, or reductions in, reimbursement amounts or rates or elimination
  of coverage for certain individuals or treatments. Moreover, because government-funded programs generally provide for reimbursements
  on a fee-schedule basis rather than on a charge-related basis, we generally cannot increase our revenues from these programs by
  increasing the amount we charge for services rendered by NWC's physicians. To the extent our costs increase, we may not
  be able to recover our increased costs from these programs, and cost containment measures and market changes in non-government-funded
  insurance plans have generally restricted our ability to recover, or shift to non-governmental payors, these increased costs.
  In addition, funds we receive from third-party payors are subject to audit with respect to the proper billing for physician and
  ancillary services and, accordingly, our revenue from these programs may be adjusted retroactively. Any retroactive adjustments
  to our reimbursement amounts could have a material effect on our financial condition, results of operations, cash flows and the
  trading price of our common stock.
  We
  may become subject to billing investigations by federal and state government authorities.
  Federal
  and state laws, rules and regulations impose substantial penalties, including criminal and civil fines, exclusion from participation
  in government healthcare programs and imprisonment, on entities or individuals (including any individual corporate officers or
  physicians deemed responsible) that fraudulently or wrongfully bill government-funded programs or other third-party payors for
  healthcare services. CMS issued a final rule requiring states to implement a Medicaid Recovery Audit Contractor ("RAC")
  program effective January 1, 2012. States are required to contract with one or more eligible Medicaid RACs to review Medicaid
  claims for any overpayments or underpayments, and to recoup overpayments from providers on behalf of the state. In addition, federal
  laws, along with a growing number of state laws, allow a private person to bring a civil action in the name of the government
  for false billing violations. We believe that audits, inquiries and investigations from government agencies will occur from time
  to time in the ordinary course of NWC's operations, which could result in substantial defense costs to us and a diversion
  of management's time and attention. We cannot predict whether any future audits, inquiries or investigations, or the public
  disclosure of such matters, would have a material adverse effect on our business, financial condition, results of operations,
  cash flows and the trading price of our common stock.
  12
  Table of Contents
  We
  may not appropriately record or document the services provided by our physicians.
  We
  must appropriately record and document the services our doctors provide to seek reimbursement for their services from third-party
  payors. If our physicians do not appropriately document, or where applicable, code for their services, we could be subjected to
  administrative, regulatory, civil, or criminal investigations or sanctions and our business, financial condition, results of operations
  and cash flows could be adversely affected.
  We
  may not be able to successfully recruit and retain qualified physicians, who are key to NWC's revenues and billing
  .
  As
  part of our business plan, we may acquire other medical practices as we see fit to further develop, test and deploy the HealthLynked
  Network into new strategic regional areas throughout the country. We compete with many types of healthcare providers, including
  teaching, research and government institutions, hospitals and health systems and other practice groups, for the services of qualified
  doctors. We may not be able to continue to recruit new physicians or renew contracts with existing physicians on acceptable terms.
  If we do not do so, our ability to service execute our business plan may be adversely affected. Our founder, Dr. Michael Dent,
  retired in 2016 from seeing patients. We are in the process of replacing him with an experienced physician who is qualified to
  perform surgeries. If we are unable to replace Dr. Dent, or to find a physician who can perform the same types of procedures,
  including surgeries, it could have a material adverse effect on the operations of NWC. Patient service revenue decreased by $592,068,
  or 23%, from the year ended December 31, 2015 to 2016, and by $37,449, or 7%, from the three months ended March 31, 2016 to the
  same period of 2017, primarily as a result of Dr. Dent's retirement in February 2016 and a decrease in production by the
  physician staff, resulting in a decrease in gross billings of approximately 16% from the year ended December 31, 2015 to 2016
  and 5% from the three months ended March 31, 2016 to the same period of 2017.
  A
  significant number of NWC physicians could leave our practice and we may be unable to enforce the non-competition covenants of
  departed employees.
  We
  have entered into employment agreements with the current NWC physicians. Certain of our employment agreements can be terminated
  without cause by any party upon prior written notice. In addition, substantially all of our physicians have agreed not to compete
  with us within a specified geographic area for a certain period after termination of employment. The law governing non-compete
  agreements and other forms of restrictive covenants varies from state to state. Although we believe that the non-competition and
  other restrictive covenants applicable to our affiliated physicians are reasonable in scope and duration and therefore enforceable
  under applicable state law, courts and arbitrators in some states are reluctant to strictly enforce non-compete agreements and
  restrictive covenants against physicians. Our physicians may leave our practices for a variety of reasons, including providing
  services for other types of healthcare providers, such as teaching, research and government institutions, hospitals and health
  systems and other practice groups. If a substantial number of our physicians leave our practices or we are unable to enforce the
  non-competition covenants in the employment agreements, our business, financial condition, results of operations and cash flows
  could be materially, and adversely affected. We cannot predict whether a court or arbitration panel would enforce these covenants
  in any particular case.
  We
  may be subject to medical malpractice and other lawsuits not covered by insurance.
  Our
  business entails an inherent risk of claims of medical malpractice against our affiliated physicians and us. We may also be subject
  to other lawsuits which may involve large claims and significant defense costs. Although we currently maintain liability insurance
  coverage intended to cover professional liability and other claims, there can be no assurance that our insurance coverage will
  be adequate to cover liabilities arising out of claims asserted against us. Liabilities in excess of our insurance coverage, including
  coverage for professional liability and other claims, could have a material adverse effect on our business, financial condition,
  results of operations, cash flows and the trading price of our common stock. See "Description of Our Business-Professional
  and General Liability Coverage."
  13
  Table of Contents
  We
  may not be able to collect reimbursements for our services from third-party payors in a timely manner.
  A
  significant portion of our net patient service revenue is derived from reimbursements from various third-party payors, including
  GHC Programs
  , private insurance plans and managed care plans, for services provided
  by NWC physicians. We are responsible for submitting reimbursement requests to these payors and collecting the reimbursements,
  and we assume the financial risks relating to uncollectible and delayed reimbursements. In the current healthcare environment,
  payors continue their efforts to control expenditures for healthcare, including revisions to coverage and reimbursement policies.
  Due to the nature of our business and our participation in government-funded and private reimbursement programs, we are involved
  from time to time in inquiries, reviews, audits and investigations by governmental agencies and private payors of our business
  practices, including assessments of our compliance with coding, billing and documentation requirements. We may be required to
  repay these agencies or private payors if a finding is made that we were incorrectly reimbursed, or we may be subjected to pre-payment
  reviews, which can be time-consuming and result in non-payment or delayed payment for the services we provide. We may also experience
  difficulties in collecting reimbursements because third-party payors may seek to reduce or delay reimbursements to which we are
  entitled for services that our affiliated physicians have provided. In addition, GHC Programs may deny our application to become
  a participating provider that could prevent us from providing services to patients or prohibit us from billing for such services.
  If we are not reimbursed fully and in a timely manner for such services or there is a finding that we were incorrectly reimbursed,
  our revenue, cash flows and financial condition could be materially, adversely affected.
  Certain
  federal and state laws may limit our effectiveness at collecting monies owed to us from patients.
  We
  utilize third parties to collect from patients any co-payments and other payments for services that are provided by NWC physicians.
  The federal Fair Debt Collection Practices Act restricts the methods that third-party collection companies may use to contact
  and seek payment from consumer debtors regarding past due accounts. State laws vary with respect to debt collection practices,
  although most state requirements are similar to those under the Fair Debt Collection Practices Act. T
  he
  Florida Consumer Collection Practices Act, is broader than the federal legislation, applying the regulations to "creditors"
  as well as "collectors," whereas the
  Fair Debt Collection Practices Act
  is
  applicable only to collectors. This prohibits creditors who are attempting to collect their own debts from engaging in behavior
  prohibited by the
  Fair Debt Collection Practices Act
  and Florida Consumer Collection
  Practices Act. The Act has very specific guidelines regarding which actions debt collectors and creditors may engage in to collect
  unpaid debt.
  If our collection practices or those of our collection agencies are inconsistent with these standards, we
  may be subject to actual damages and penalties. These factors and events could have a material adverse effect on our business,
  financial condition and results of operations.
  We
  may not be able to maintain effective and efficient information systems.
  The
  profitability of our business, including the services provided by NWC, is dependent on uninterrupted performance of our information
  systems. Failure to maintain reliable information systems, disruptions in our existing information systems or the implementation
  of new systems could cause disruptions in our business operations, including errors and delays in billings and collections, disputes
  with patients and payors, violations of patient privacy and confidentiality requirements and other regulatory requirements, increased
  administrative expenses and other adverse consequences.
  RISKS
  RELATING TO OUR ORGANIZATION
  Our
  articles of incorporation authorize our board to create a new series of preferred stock without further approval by our stockholders,
  which could adversely affect the rights of the holders of our common stock.
  Our
  board of directors has the authority to fix and determine the relative rights and preferences of preferred stock. Our board of
  directors also has the authority to issue preferred stock without further stockholder approval. As a result, our board of directors
  could authorize the issuance of a series of preferred stock that would grant to holders the preferred right to our assets upon
  liquidation, the right to receive dividend payments before dividends are distributed to the holders of common stock and the right
  to the redemption of the shares, together with a premium, prior to the redemption of our common stock. In addition, our board
  of directors could authorize the issuance of a series of preferred stock that has greater voting power than our common stock or
  that is convertible into our common stock, which could decrease the relative voting power of our common stock or result in dilution
  to our existing stockholders.
  14
  Table of Contents
  Stockholders'
  ability to influence corporate decisions may be limited because Michael Dent, our Chief Executive Officer and Chairman of the
  Board, currently owns a controlling percentage of our common stock.
  Currently,
  Dr. Dent, our Chief Executive Officer and Chairman of the Board, beneficially owns approximately 72.39% of our outstanding common
  stock. As a result of this stock ownership, Dr. Dent can control all matters submitted to our stockholders for approval, including
  the election of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. This concentration
  of voting power could delay or prevent an acquisition of our company on terms that other stockholders may desire. In addition,
  as the interests of Dr. Dent and our minority stockholders may not always be the same, this large concentration of voting power
  may lead to stockholder votes that are inconsistent with the best interests of our minority stockholders or the best interest
  of the Company as a whole.
  If
  we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results
  accurately or to prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation
  and adversely impact the trading price of our common stock.
  Effective
  internal control is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable financial
  reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment
  existed, and our business and reputation with investors may be harmed. As a result, our small size and any current internal control
  deficiencies may adversely affect our financial condition, results of operation and access to capital. We have not performed an
  in-depth analysis to determine if historical un-discovered failures of internal controls exist, and may in the future discover
  areas of our internal control that need improvement.
  We
  are required to comply with the Commission's rules implementing Section 302 of the Sarbanes-Oxley Act of 2002, which require
  our management to certify financial and other information in our quarterly and annual reports and provide an annual management
  report on the effectiveness of our internal control over financial reporting. However, we will not be required to make our first
  assessment of our internal control over financial reporting until the year following our first annual report required to be filed
  with the Commission. To comply with the requirements of being a public company, we will need to implement additional financial
  and management controls, reporting systems and procedures and hire accounting, finance and legal staff.
  Further,
  our independent registered public accounting firm is not yet required to formally attest to the effectiveness of our internal
  controls over financial reporting, and will not be required to do so for as long as we are an "emerging growth company"
  pursuant to the provisions of the JOBS Act. Please read "Summary—Emerging Growth Company Status."
  Public
  company compliance may make it more difficult to attract and retain officers and directors.
  The
  Sarbanes-Oxley Act and new rules subsequently implemented by the Commission have required changes in corporate governance practices
  of public companies. As a public company, we expect these new rules and regulations to increase our compliance costs and to make
  certain activities more time consuming and costly. As a public company, we also expect that these new rules and regulations may
  make it more difficult and expensive for us to obtain director and officer liability insurance in the future and we may be required
  to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a
  result, it may be more difficult for us to attract and retain qualified persons to serve on our board of directors or as executive
  officers.
  The
  public market for our common stock is new and extremely limited.  Failure to develop or maintain a trading market could
  negatively affect its value and make it difficult or impossible for you to sell your shares.
  Our
  common stock has traded on the OTCQB under the symbol "HLYK" since May 10, 2017.  There is a limited public
  market for our common stock and an active public market for our common stock may not develop.  Failure to develop or
  maintain an active trading market could make it difficult for you to sell your shares or recover any part of your investment in
  us.  Even if a market for our common stock does develop, the market price of our common stock may be highly volatile.  In
  addition to the uncertainties relating to future operating performance and the profitability of operations, factors such as variations
  in interim financial results or various, as yet unpredictable, factors, many of which are beyond our control, may have a negative
  effect on the market price of our common stock.
  15
  Table of Contents
  Our
  common stock is subject to the "penny stock" rules of the Commission and the trading market in the securities is limited,
  which makes transactions in our common stock cumbersome and may reduce the value of an investment in our common stock.
  Rule
  15g-9 under the Securities Exchange Act of 1934, as amended (the "Exchange Act") establishes the definition of a "penny
  stock," for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or
  with an exercise price of less than $5.00 per share, subject to certain exceptions.  For any transaction involving a penny
  stock, unless exempt, the rules require: (a) that a broker or dealer approve a person's account for transactions in penny
  stocks; and (b) the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity
  and quantity of the penny stock to be purchased.
  In
  order to approve a person's account for transactions in penny stocks, the broker or dealer must: (a) obtain financial information
  and investment experience objectives of the person and (b) make a reasonable determination that the transactions in penny stocks
  are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating
  the risks of transactions in penny stocks.
  The
  broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the Commission
  relating to the penny stock market, which, in highlight form: (a) sets forth the basis on which the broker or dealer made the
  suitability determination; and (b) confirms that the broker or dealer received a signed, written agreement from the investor prior
  to the transaction.  Generally, brokers may be less willing to execute transactions in securities subject to the "penny
  stock" rules.  This may make it more difficult for investors to dispose of our Common Stock and cause a decline in
  the market value of our Common Stock.
  Disclosure
  also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the
  commissions payable to both the broker or dealer and the registered representative, current quotations for the securities and
  the rights and remedies available to an investor in cases of fraud in penny stock transactions.  Finally, monthly statements
  have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market
  in penny stocks.
  Offers
  or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.
  If
  our stockholders sell substantial amounts of our common stock in the public market, including upon the expiration of any statutory
  holding period under Rule 144 or registration for resale, or issued upon the conversion of convertible notes, or exercise of warrants,
  it could create a circumstance commonly referred to as an "overhang" and in anticipation of which the market price of
  our common stock could fall.  As of the date of this prospectus, we currently have 7,375,000 shares underlying convertible
  notes that have been registered for resale pursuant to an effective registration statement on Form S-1 (File No. 333-215963),
  up to $3,000,000 worth of shares that have been registered for resale pursuant to an effective registration statement on Form
  S-1 (File No, 333-217309) and 3,517,496 shares of common stock that we are registering for resale pursuant to this reoffer prospectus.
  The existence of an overhang, whether or not sales have occurred or are occurring, also could make more difficult our ability
  to raise additional financing through the sale of equity or equity-related securities in the future at a time and price that we
  deem reasonable or appropriate.  Further, a substantial number of shares of common stock are being offered by this prospectus,
  and we cannot predict if and when the purchasers may sell such shares in the public markets. In addition, we cannot predict the
  number of these shares that might be sold nor the effect that future sales of our shares of common stock would have on the market
  price of our shares of common stock.
  16
  Table of Contents
  Drawdowns
  under the Investment Agreement may cause dilution to existing shareholders.
  Iconic,
  our counterparty in the Investment Agreement, has committed to purchase up to $3,000,000 worth of shares of our common stock.
  From time to time during the term of the Investment Agreement, and at our sole discretion, we may present Iconic with a put notice
  requiring Iconic to purchase shares of our common stock. The purchase price to be paid by Iconic will be 80% of the lowest volume
  weighted average price of our common stock during the five consecutive trading days prior to the date on which written notice
  is sent by us to the investor stating the number of shares that the Company is selling to the investor, subject to certain adjustments.
  As a result, our existing shareholders will experience immediate dilution upon the purchase of any of the shares by Iconic. The
  issue and sale of the shares under the Investment Agreement may also have an adverse effect on the market price of the common
  shares. Iconic may resell some, if not all, of the shares that we issue to it under the Investment Agreement and such sales could
  cause the market price of the common stock to decline significantly. To the extent of any such decline, any subsequent puts would
  require us to issue and sell a greater number of shares to Iconic in exchange for each dollar of the put amount. Under these circumstances,
  the existing shareholders of our company will experience greater dilution. The effect of this dilution may, in turn, cause the
  price of our common stock to decrease further, both because of the downward pressure on the stock price that would be caused by
  a large number of sales of our shares into the public market by Iconic, and because our existing stockholders may disagree with
  a decision to sell shares to Iconic at a time when our stock price is low, and may in response decide to sell additional shares,
  further decreasing our stock price. If we draw down amounts under the Investment Agreement when our share price is decreasing,
  we will need to issue more shares to raise the same amount of funding.
  Certain
  restrictions on the extent of puts and the delivery of advance notices may have little, if any, effect on the adverse impact of
  our issuance of shares in connection with the Investment Agreement and as such, Iconic may sell a large number of shares, resulting
  in substantial dilution to the value of shares held by existing stockholders.
  Iconic
  has agreed, subject to certain exceptions listed in the investment agreement with Iconic, to refrain from holding an amount of
  shares which would result in Iconic or its affiliates owning more than 9.99% of the then-outstanding shares of our common stock
  at any one time. These restrictions, however, do not prevent Iconic from selling shares of our common stock received in connection
  with a put, and then receiving additional shares of our common stock in connection with a subsequent put. In this way, Iconic
  could sell more than 9.99% of the outstanding common stock in a relatively short time frame while never holding more than 9.99%
  at one time.
  17
  Table of Contents
  USE
  OF PROCEEDS
  The
  shares which may be sold under this reoffer prospectus will be sold for the respective accounts of each of the Selling Securityholders
  listed herein (which includes our executive officers and directors). Accordingly, we will not realize any proceeds from the sale
  of the shares of our common stock. We will receive proceeds from the exercise of the options; however, no assurance can be given
  as to when or if any or all of the options will be exercised. If any options are exercised, the proceeds derived therefrom will
  be used for working capital and general corporate purposes. All expenses of the registration of the shares will be paid by us.
  See "Selling Securityholders" and "Plan of Distribution."
  18
  Table of Contents
  SELLING
  SECURITYHOLDERS
  We
  are registering for resale the shares covered by this prospectus to permit the Selling Securityholders identified below and their
  pledgees, donees, transferees and other successors-in-interest that receive their securities from a Selling Securityholder as
  a gift, partnership distribution or other non-sale related transfer after the date of this prospectus to resell the shares when
  and as they deem appropriate. The Selling Securityholders acquired, or may acquire, these shares from us pursuant to the Plan.
  The shares may not be sold or otherwise transferred by the Selling Securityholders unless and until the applicable awards vest
  and are exercised, as applicable, in accordance with the terms and conditions of the Plan. The amount of shares to be reoffered
  or resold by means of this prospectus by each Selling Securityholder, and any other person with whom such Selling Securityholder
  is acting in concert for the purpose of selling our securities, may not exceed, during any three-month period, the amount specified
  in Rule 144(e) of the Securities Act. Although a person's name is included in the table below, neither that person nor we
  are making an admission that the named person is our "affiliate."
  The
  following table sets forth:
  ●
  the
      name of each Selling Securityholder;
  ●
  the
      position(s), office or other material relationship with our company and its predecessors or affiliates, over the last three
      years of each Selling Securityholder;
  ●
  the
      number and percentage of shares of our common stock that each Selling Securityholder beneficially owned as of May 19, 2017
      prior to the offering for resale of the shares under this prospectus;
  ●
  the
      number of shares of our common stock that may be offered for resale for the account of each Selling Securityholder under this
      prospectus; and
  ●
  the
      number and percentage of shares of our common stock to be beneficially owned by each Selling Securityholder after the offering
      of the resale shares (assuming all of the offered resale shares are sold by such Selling Securityholder).
  Information
  with respect to beneficial ownership is based upon information obtained from the Selling Securityholders.  Because the
  Selling Securityholders may offer all or part of the shares of common stock, which they own pursuant to the offering contemplated
  by this reoffer prospectus, and because its offering is not being underwritten on a firm commitment basis, no estimate can be
  given as to the amount of shares that will be held upon termination of this offering.
  19
  Table of Contents
  The
  number of shares in the column ''Number of Shares Being Offered'' represents all of the shares of our
  common stock that each Selling Securityholder may offer under this prospectus. We do not know how long the Selling Securityholders
  will hold the shares before selling them or how many shares they will sell. The shares of our common stock offered by this prospectus
  may be offered from time to time by the Selling Securityholders listed below. We cannot assure you that any of the Selling Securityholders
  will offer for sale or sell any or all of the shares of common stock offered by them by this prospectus.
  Number of Shares Beneficially Owned Prior to Offering (1)
  Number of Shares
  Number of Shares Beneficially Owned After Offering (2)
  Securityholders
  Position
  Number
  Percent (%)
  Being Offered
  Number
  Percent (%)
  Michael T. Dent (3)
  Chief Executive Officer and Chairman
  52,053,640
  72.39
  %
  1,000,000
  51,853,640
  72.32
  %
  George O'Leary (4)
  Chief Financial Officer and Director
  2,300,000
  3.29
  %
  600,000
  2,100,000
  3.01
  %
  Robert Horel (5)
  Chief Marketing Officer
  ---
  ---
  449,996
  ---
  ---
  Carolyn Monaco (6)
  Current employee
  3,312,500
  4.75
  %
  212,500
  3,100,000
  4.45
  %
  Cindy Troy (7)
  Current employee
  322,500
  **
  262,500
  60,000
  **
  Jennie Sanderson (8)
  Current employee
  207,500
  **
  147,500
  60,000
  **
  Kara Brogan (9)
  Current employee
  122,500
  **
  122,500
  ---
  ---
  Leila Sakhai (9)
  Current employee
  102,500
  **
  102,500
  ---
  ---
  Jean Burton (9)
  Current employee
  102,500
  **
  102,500
  ---
  ---
  Terri Caton (9)
  Former employee
  12,500
  **
  12,500
  ---
  ---
  Katherine Zea (9)
  Current employee
  47,500
  **
  47,500
  ---
  ---
  Mary Cooper (9)
  Current employee
  47,500
  **
  47,500
  ---
  ---
  Laurie Whitt (9)
  Current employee
  37,500
  **
  37,500
  ---
  ---
  Wendy Pulver (9)
  Current employee
  27,500
  **
  27,500
  ---
  ---
  Dana Howell (9)
  Former employee
  42,500
  **
  42,500
  ---
  ---
  Sherry Terlecki (9)
  Current employee
  62,500
  **
  62,500
  ---
  ---
  Erin Adams (9)
  Current employee
  37,500
  **
  37,500
  ---
  ---
  Anilegna Betancourt (9)
  Current employee
  27,500
  **
  27,500
  ---
  ---
  Maricet Camuzo (9)
  Current employee
  27,500
  **
  27,500
  ---
  ---
  Isabel Castro (9)
  Current employee
  27,500
  **
  27,500
  ---
  ---
  Melissa Kopczynski (9)
  Current employee
  27,500
  **
  27,500
  ---
  ---
  Eileen Clark (9)
  Current employee
  27,500
  **
  27,500
  ---
  ---
  Kelly Tyson (9)
  Current employee
  27,500
  **
  27,500
  ---
  ---
  Doug Charles (9)
  Current employee
  37,500
  **
  37,500
  ---
  ---
  **  less
  than 1%
  (1)
  The
      number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Exchange Act, and the
      information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, beneficial ownership
      includes any shares as to which the Selling Securityholder has sole or shared voting power or investment power and also any
      shares which the Selling Securityholder has the right to acquire within 60 days. Applicable percentage ownership is based
      on 69,703,640 shares of common stock outstanding as of May 19, 2017.
  (2)
  Assumes
      that all shares of common stock to be offered, as set forth above, are sold pursuant to this offering and that no other shares
      of common stock are acquired or disposed of by the Selling Securityholders prior to the termination of this offering. Because
      the Selling Securityholders may sell all, some or none of their shares of common stock or may acquire or dispose of other
      shares of common stock, no reliable estimate can be made of the aggregate number of shares of common stock that will be sold
      pursuant to this offering or the number or percentage of shares of common stock that each Selling Securityholder will own
      upon completion of this offering.
  20
  Table of Contents
  (3)
  Beneficial
      ownership prior to the offering includes 2,953,640 shares of common stock held by Dr. Dent directly, 46,900,000 shares of
      common stock held in the name of Mary S. Dent Gifting Trust Common, 2,000,000 shares of common stock issuable upon exercise
      of warrants with an exercise price of $0.05 and 200,000 shares issuable upon exercise of vested employee stock options with
      an exercise price of $0.08. Excludes 800,000 shares issuable upon exercise of employee stock options with an exercise price
      of $0.08 which are subject to future vesting requirements and are not expected to vest within 60 days of May 19, 2017.  Shares
      being offered includes 1,000,000 shares of common stock issuable upon exercise of stock options.
  (4)
  Beneficial
      ownership prior to the offering includes 2,100,000 shares of common stock held by SKS Consulting of South Florida Corp., a
      corporation directly controlled by George O'Leary and 200,000 shares issuable upon exercise of vested employee stock
      options with an exercise price of $0.08 held by George O'Leary directly. Excludes shares issuable upon exercise of 400,000
      employee stock options held by George O'Leary directly with an exercise price of $0.08 which are subject to future vesting
      requirements and are not expected to vest within 60 days of May 19, 2017.  Shares being offered include all 600,000
      shares issuable upon exercise of employee stock options held by George O'Leary directly.
  (5)
  Beneficial
      ownership prior to the offering excludes 449,996 shares issuable upon exercise of employee stock options with an exercise
      price of $0.20 which are subject to future vesting requirements, none of which are vested or expected to vest within 60 days
      of May 19, 2017, and all of which are being offered hereunder.
  (6)
  Beneficial
      ownership prior to the offering includes (i) 3,100,000 shares of common stock acquired by Carolyn Monaco in 2014 not being
      offered hereunder, and (ii) 212,500 shares of common stock issued under the Plan being offered hereunder.
  (7)
  Beneficial
      ownership prior to the offering includes (i) 60,000 shares of common stock acquired by Cindy Troy in 2014 not being offered
      hereunder, and (ii) 262,500 shares of common stock issued under the Plan being offered hereunder.
  (8)
  Beneficial
      ownership prior to the offering includes (i) 60,000 shares of common stock acquired by Jennie Sanderson in 2014 not being
      offered hereunder, and (ii) 147,500 shares of common stock issued under the Plan being offered hereunder.
  (9)
  Includes
      shares of common stock issued under the Plan.
  21
  Table of Contents
  PLAN
  OF DISTRIBUTION
  The
  Selling Securityholders and any of their respective pledgees, donees, assignees and other successors-in-interest may, from time
  to time, sell any or all of their shares of our common stock on any stock exchange, market or trading facility on which the shares
  are traded or in private transactions. These sales may be at fixed or negotiated prices. The amount of shares to be reoffered
  or resold by means of this prospectus by each Selling Securityholder, and any other person with whom such Selling Securityholder
  is acting in concert for the purpose of selling our securities, may not exceed, during any three-month period, the amount specified
  in Rule 144(e) of the Securities Act. The Selling Securityholders may use any one or more of the following methods when
  selling shares:
  ●
  ordinary
      brokerage transactions and transactions in which the broker-dealer solicits purchasers;
  ●
  block
      trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block
      as principal to facilitate the transaction;
  ●
  purchases
      by a broker-dealer as principal and resale by the broker-dealer for its account;
  ●
  an
      exchange distribution in accordance with the rules of the applicable exchange;
  ●
  privately
      negotiated transactions;
  ●
  short
      sales after this registration statement becomes effective;
  ●
  broker-dealers
      may agree with the Selling Securityholders to sell a specified number of such shares at a stipulated price per share;
  ●
  through
      the writing of options on the shares;
  ●
  a
      combination of any such methods of sale; and
  ●
  any
      other method permitted pursuant to applicable law.
  The
  Selling Securityholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.
  The Selling Securityholders will have the sole and absolute discretion not to accept any purchase offer or make any sale of shares
  if they deem the purchase price to be unsatisfactory at any particular time.
  The
  Selling Securityholders may also engage in short sales against the box after this registration statement becomes effective, puts
  and calls and other transactions in our securities or derivatives of our securities and may sell or deliver shares in connection
  with these trades.
  The
  Selling Securityholders or their respective pledges, donees, transferees or other successors in interest, may also sell the shares
  directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers. Such
  broker-dealers may receive compensation in the form of discounts, concessions or commissions from the Selling Securityholders
  and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which
  compensation as to a particular broker-dealer might be in excess of customary commissions. Market makers and block purchasers
  purchasing the shares of common stock in block transactions to market makers or other purchasers at a price per share which may
  be below the then market price. The Selling Securityholders cannot assure that all or any of the shares offered in this prospectus
  will be issued to, or sold by, the Selling Securityholders. The Selling Securityholders and any brokers, dealers or agents, upon
  effecting the sale of any of the shares offered in this prospectus, may be deemed to be ''underwriters''
  as that term is defined under the Securities Act or the Exchange Act, or the rules and regulations under such acts. In such event,
  any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be
  deemed to be underwriting commissions or discounts under the Securities Act.
  22
  Table of Contents
  Discounts,
  concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by the Selling
  Securityholders. The Selling Securityholders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions
  involving sales of the shares if liabilities are imposed on that person under the Securities Act.
  The
  Selling Securityholders may from time to time pledge or grant a security interest in some or all of the shares of common stock
  owned by them and, if they default in the performance of their secured obligations, the pledge or secured parties may offer and
  sell the shares of common stock from time to time under this prospectus after we have filed an amendment to this prospectus under
  Rule 424(b)(3) or any other applicable provision of the Securities Act amending the list of Selling Securityholders to include
  the pledge, transferee or other successors in interest as Selling Securityholders under this prospectus.
  The
  Selling Securityholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledges
  or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares
  of common stock from time to time under this prospectus after we have filed an amendment to this prospectus under Rule 424(b)(3)
  or other applicable provision of the Securities Act amending the list of Selling Securityholders to include the pledge, transferee
  or other successors in interest as Selling Securityholders under this prospectus.
  Each
  of the Selling Securityholders acquired the securities offered hereby in the ordinary course of business and have advised us that
  they have not entered into any agreements, understandings or arrangements with any underwriters or broker-dealers regarding the
  sale of their shares of common stock, nor is there an underwriter or coordinating broker acting in connection with a proposed
  sale of shares of common stock by any Selling Securityholder. If we are notified by any Selling Securityholder that any material
  arrangement has been entered into with a broker-dealer for the sale of shares of common stock, if required, we will file a supplement
  to this prospectus. If the Selling Securityholders use this prospectus for any sale of the shares of common stock, they will be
  subject to the prospectus delivery requirements of the Securities Act.
  The
  anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of our common stock and activities of the Selling
  Securityholders.
  We
  will bear all costs, expenses and fees in connection with the registration of the common stock offered hereby. However, the Selling
  Securityholders will bear any brokerage or underwriting commissions and similar selling expenses, if any, attributable to the
  sale of the shares of common stock offered pursuant to this reoffer prospectus. We have agreed to indemnify certain of the Selling
  Securityholders against certain liabilities, including liabilities under the Act, or to contribute to payments to which any of
  those security holders may be required to make in respect thereof.
  There
  can be no assurance that the Selling Securityholders will sell any or all of the securities offered by them hereby.
  LEGAL
  MATTERS
  The
  validity of the issuance of the securities offered by this prospectus will be passed upon for us by Sichenzia Ross Ference
  Kesner LLP, New York, New York.
  EXPERTS
  Our
  audited financial statements as of December 31, 2016 and 2015 have been included in this prospectus in reliance on the report
  of RBSM LLP, an independent registered public accounting firm appearing elsewhere herein given on the authority of said firm as
  experts in auditing and accounting.
  23
  Table of Contents
  INCORPORATION
  OF CERTAIN DOCUMENTS BY REFERENCE
  The
  following documents, heretofore filed by us with the Commission pursuant to the Securities Act or the Exchange Act, are hereby
  incorporated by reference, except as superseded or modified herein:
  1.
  Quarterly
                                           Report on Form 10-Q filed on May 15, 2017;
  2.
  Current
                                           Reports on Form 8-K (excluding any reports or portions thereof that are deemed to
                                           be furnished and not filed) filed on May 16, 2017 and May 10, 2017;
  3.
  Amendment
                                           No. 1 to the Registrant's Registration Statement on Form S-1 (File No. 333-217309)
                                           under the Securities Act filed on May 12, 2017; and
  4.
  Amendment
                                           No. 2 to the Registrant's Registration Statement on Form S-1 (File No. 333-215963)
                                           under the Securities Act filed on March 23, 2017; and
  5.
  The
                                           description of the Company's common stock, par value $0.0001 per share, contained
                                           in the Registrant's Form 8-A filed under the Exchange Act on April 14, 2017
                                           and any amendment or report filed for the purpose of updating such description.
  All
  documents that we file with the Commission pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act (other than
  any report or portion thereof furnished or deemed furnished under any Current Report on Form 8-K) subsequent to the date
  of this registration statement and prior to the filing of a post-effective amendment to this registration statement that indicates
  that all securities offered under this reoffer prospectus have been sold, or that deregisters all securities then remaining unsold,
  will be deemed to be incorporated in this registration statement by reference and to be a part hereof from the date of filing
  of such documents.
  Any
  statement contained in a document we incorporate by reference will be modified or superseded for all purposes to the extent that
  a statement contained in this reoffer prospectus (or in any other document that is subsequently filed with the Commission and
  incorporated by reference) modifies or is contrary to that previous statement. Any statement so modified or superseded will not
  be deemed part of this reoffer prospectus except as so modified or superseded.
  We
  will provide without charge to each person to whom a copy of this reoffer prospectus is delivered, upon the written or oral request
  of any such person, a copy of any document described above (other than exhibits). Requests for such copies should be directed
  to HealthLynked Corp., 1726 Medical Blvd., Suite 101, Naples, Florida 34110, Attention: CFO, telephone number: (
  239)
  513-1992
  .
  You
  should rely only on the information incorporated by reference or provided in this reoffer prospectus or any prospectus supplement.
  We have not authorized anyone else to provide you with different information. You should not assume that the information in this
  reoffer prospectus or any prospectus supplement is accurate as of any date other than the date on the front page of those
  documents.
  DISCLOSURE
  OF COMMISSION POSITION ON INDEMNIFICATION
  FOR
  SECURITIES ACT LIABILITIES
  Insofar
  as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling
  the registrant, the registrant has been informed that in the opinion of the Commission such indemnification is against public
  policy as expressed in the Securities Act and is therefore unenforceable.
  WHERE YOU
  CAN FIND MORE INFORMATION
  We
  are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, and in accordance therewith
  file annual, quarterly and current reports and other information with the Securities and Exchange Commission. Such reports and
  other information can be read and copied at the Securities and Exchange Commission's public reference facilities at 100
  F Street, N.E., Washington, D.C. 20549, at prescribed rates. Please call the Securities and Exchange Commission at 1-800-732-0330
  for further information on the operation of the public reference facilities. In addition, the Securities and Exchange Commission
  maintains a website that contains reports and information statements and other information regarding registrants that file electronically
  with the Securities and Exchange Commission. The address of the Securities and Exchange Commission's website is
  www.sec.gov
  .
  We
  make available free of charge on or through our website at www.healthlynked.com, all of our filings pursuant to the Exchange Act
  and Securities Act, as soon as reasonably practicable after we electronically file such material with or otherwise furnish it
  to the Securities and Exchange Commission. Information on our website is not incorporated by reference in this prospectus and
  is not a part of this prospectus.
  24
  Table of Contents
  HEALTHLYNKED
  CORP.
  3,517,496
  SHARES OF COMMON STOCK
  REOFFER
  PROSPECTUS
  May
  22, 2017
  Table of Contents
  PART
  II
  INFORMATION
  NOT REQUIRED IN THE PROSPECTUS
  Item
  3. Incorporation of Documents by Reference.
  The
  following documents, heretofore filed by us with the Commission pursuant to the Securities Act or the Exchange Act, are hereby
  incorporated by reference, except as superseded or modified herein:
  1.
  Quarterly
                                           Report on Form 10-Q filed on May 15, 2017
  2.
  Current
                                           Reports on Form 8-K (excluding any reports or portions thereof that are deemed to
                                           be furnished and not filed) filed on May 16, 2017 and May 10, 2017;
  3.
  Amendment
                                           No. 1 to the Registrant's Registration Statement on Form S-1 (File No. 333-217309)
                                           under the Securities Act filed on May 12, 2017; and
  4.
  Amendment
                                           No. 2 to the Registrant's Registration Statement on Form S-1 (File No. 333-215963)
                                           under the Securities Act filed on March 23, 2017; and
  5.
  The
                                           description of the Company's common stock, par value $0.0001 per share, contained
                                           in the Registrant's Form 8-A filed under the Exchange Act on April 14, 2017
                                           and any amendment or report filed for the purpose of updating such description.
  All
  documents that we file with the Commission pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act (other than
  any report or portion thereof furnished or deemed furnished under any Current Report on Form 8-K) subsequent to the date
  of this registration statement and prior to the filing of a post-effective amendment to this registration statement that indicates
  that all securities offered under this reoffer prospectus have been sold, or that deregisters all securities then remaining unsold,
  will be deemed to be incorporated in this registration statement by reference and to be a part hereof from the date of filing
  of such documents.
  Any
  statement contained in a document we incorporate by reference will be modified or superseded for all purposes to the extent that
  a statement contained in this reoffer prospectus (or in any other document that is subsequently filed with the Commission and
  incorporated by reference) modifies or is contrary to that previous statement. Any statement so modified or superseded will not
  be deemed part of this reoffer prospectus except as so modified or superseded.
  We
  will provide without charge to each person to whom a copy of this reoffer prospectus is delivered, upon the written or oral request
  of any such person, a copy of any document described above (other than exhibits). Requests for such copies should be directed
  to HealthLynked Corp., 1726 Medical Blvd., Suite 101, Naples, Florida 34110, Attention: CFO, telephone number: (
  239)
  513-1992
  .
  You
  should rely only on the information incorporated by reference or provided in this reoffer prospectus or any prospectus supplement.
  We have not authorized anyone else to provide you with different information. You should not assume that the information in this
  reoffer prospectus or any prospectus supplement is accurate as of any date other than the date on the front page of those
  documents.
  Item
  4.  Description of Securities.
  Not
  applicable.
  Item
  5.  Interests of Named Experts and Counsel.
  Not
  applicable.
  II-
  1
  Table of Contents
  Item
  6.  Indemnification of Directors and Officers.
  Nevada
  Revised Statutes ("NRS") Sections 78.7502 and 78.751 provide us with the power to indemnify any of our directors and
  officers. The director or officer must have conducted himself/herself in good faith and reasonably believe that his/her conduct
  was in, or not opposed to, our best interests. In a criminal action, the director, officer, employee or agent must not have had
  reasonable cause to believe his/her conduct was unlawful.
  Under
  NRS Section 78.751, advances for expenses may be made by agreement if the director or officer affirms in writing that he/she believes
  he/she has met the standards and will personally repay the expenses if it is determined such officer or director did not meet
  the standards.
  We
  are also permitted to apply for insurance on behalf of any director, officer, employee or other agent for liability arising out
  of his actions, whether or not the NRS would permit indemnification.
  Insofar
  as indemnification for liabilities arising under the Securities Act may be permitted for our directors, officers and controlling
  persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Commission such indemnification
  is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
  Item
  7.  Exemption from Registration Claimed.
  The
  restricted securities that may be reoffered or resold by the Selling Securityholders pursuant to the reoffer prospectus included
  herein were stock awards granted under the Plan and were deemed to be exempt from registration under the Securities Act, in reliance
  on Section 4(a)(2) of the Securities Act, as transactions by an issuer not involving a public offering, and/or Rule 701 under
  the Securities Act, which relates to exemptions for offers and sales of securities pursuant to certain compensatory benefit plans.
  Item
  8.  Exhibits.
  Exhibit
      Number
  Description
  4.1
  2016 Equity Incentive Plan*
  5.1
  Opinion of Sichenzia Ross Ference Kesner LLP
  23.1
  Consent of RBSM LLP
  23.2
  Consent of Sichenzia Ross Ference Kesner LLP (included in Exhibit 5.1)
  *
  Replaces version filed as Exhibit 10.17 to the Company's Draft Registration Statement on Form S-1 filed with the Commission
  on January 9, 2017, which was not a final version
  Item
  9. Undertakings.
  A.
  The undersigned Registrant hereby undertakes:
  1.
  To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
  (i)   To
  include any prospectus required by section 10(a)(3) of the Securities Act;
  (ii)  To
  reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent
  post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
  forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
  the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
  end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if,
  in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price
  set forth in the "Calculation of Registration Fee" table in the effective Registration Statement.
  II-
  2
  Table of Contents
  (iii) To
  include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement
  or any material change to such information in the Registration Statement;
  Provided,
  however,
  that paragraphs (A)(1)(i) and (A)(1)(ii) do not apply if the information required to be included in
  a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant
  pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the Registration
  Statement.
  2.
  That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
  to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time
  shall be deemed to be the initial bona fide offering thereof.
  3.
  To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
  at the termination of the offering.
  B.
  The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
  of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and,
  where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Exchange
  Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating
  to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide
  offering thereof.
  C.
  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
  persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion
  of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
  In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred
  or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding)
  is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant
  will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
  jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will
  be governed by the final adjudication of such issue.
  II-
  3
  Table of Contents
  SIGNATURES
  Pursuant
  to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe
  that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its
  behalf by the undersigned, thereunto duly authorized, in the City of Naples, State of Florida, on May 22, 2017
  HEALTHLYNKED
      CORP.
  By:
  /s/
      Michael Dent
  Michael
      Dent
  Chief
      Executive Officer and Chairman
  (Principal Executive Officer)
  By:
  /s/
      George O'Leary
  George
      O'Leary
  Chief
      Financial Officer and Director
  (Principal Accounting Officer)
  Pursuant
  to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
  capacities and on the dates indicated.
  Name
  Title
  Date
  /s/
      Michael Dent
  Chief
  Executive Officer and Chairman
  May
      22, 2017
  Michael
      Dent
  (Principal Executive Officer)
  /s/
      George O'Leary
  Chief
  Financial Officer and Director
  May
      22, 2017
  George
      O'Leary
  (Principal Accounting Officer)
  II-4